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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 91, Revision 2 
(FGE.91Rev2): Consideration of simple aliphatic and aromatic sulphides 
and thiols evaluated by the JECFA (53rd and 68th meetings) structurally 
related to aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or 
without additional oxygenated functional groups evaluated by EFSA in 
FGE.08Rev5 (2012)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to consider evaluations of flavouring substances assessed since 2000 by the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide whether further evaluation is 
necessary, as laid down in Commission Regulation (EC) No 1565/2000. The present consideration concerns a 
group of 44 simple aliphatic and aromatic sulphides and thiols evaluated by the JECFA at the 53rd and the 68th 
meeting. The substances were evaluated through a stepwise approach that integrates information on structure-
activity relationships, intake from current uses, toxicological threshold of concern, and available data on 
metabolism and toxicity. For 36 substances considered in this FGE the Panel concluded that they would pose 
“No safety concern at estimated levels of intake as flavouring substances” based on the MSDI approach For 
seven substances [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] the Panel decided, 
contrary to the JECFA that these substances could not be evaluated due to absence of a NOAEL from either one 
of these substances or from a structurally related substance. Besides the safety assessment of these flavouring 
substances, the specifications for the materials of commerce have also been considered and for all 44 substances, 
the information is adequate. For candidate substance 3-(methylthio)heptenal [FL-no: 12.273], which contains 5 
to7 %  of an α,β-unsaturated aldehyde, 2-(E)-heptenal, with a possible genotoxic potential, the Panel cannot 
conclude that the material of commerce for this candidate substance is not of safety concern, until either this 
component is cleared with respect to a concern for genotoxicity, or this component is removed from the 
commercial product. 
                                                     
1  On request from the European Commission, Question No EFSA-Q-2013-00412 to EFSA-Q-2013-00418, adopted on 21 
May 2014. 
2  Panel members: Ulla Beckman Sundh, Mona-Lise Binderup, Claudia Bolognesi, Leon Brimer, Laurence Castle, 
Alessandro Di Domenico, Karl-Heinz Engel, Roland Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter 
Jany, Martine Kolf-Clauw, Wim Mennes, Maria Rosaria Milana, Iona Pratt †, Kettil Svensson, Maria de Fátima Tavares 
Poças, Fidel Toldra and Detlef Wölfle. Correspondence: fip@efsa.europa.eu   
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Flavourings: Ulla Beckman Sundh, 
Leon Brimer, Angelo Carere, Karl-Heinz Engel, Henrik Frandsen, Rainer Gürtler, Frances Hill, Trine Husøy, Wim 
Mennes, Gerard Mulder and Harriet Wallin for the preparatory work on this scientific opinion and the hearing experts: 
Vibe Beltoft, Pia Lund and Karin Nørby and EFSA staff: Annamaria Rossi and Kim Rygaard Nielsen for the support 
provided to this scientific opinion. 
†  Deceased 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific advice to the 
Commission on the implications for human health of chemically defined flavouring substances used in 
or on foodstuffs in the Member States. In particular, the CEF Panel was requested to consider the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances 
assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in 
Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
The previous version of this consideration dealt with 47 simple aliphatic and aromatic sulphides and 
thiols, which are in the Register and which were evaluated by the JECFA at its 53rd and 68th meetings. 
Since the previous evaluation, data have become available that alleviate a concern for genotoxicity, 
which was identified in the previous version of this FGE for seven tertiary thiols. These seven 
substances can now be evaluated through the procedure. In addition, three substances are no longer 
supported by Industry. This revision of FGE.91 therefore deals with 44 substances. 
The Panel concluded that all the 44 substances in the JECFA flavouring groups of simple aliphatic and 
aromatic sulphides and thiols are structurally related to the aliphatic and alicyclic mono-, di-, tri-, and 
polysulphides with or without additional oxygenated functional groups evaluated by EFSA in the 
Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5). The 44 JECFA evaluated substances are 
distributed into six subgroups of structurally related substances. The subgrouping corresponds to the 
subgrouping in FGE.08Rev5. 
This revision is made because additional genotoxicity data have become available for 4-mercapto-4-
methyl-2-pentanone [FL-no: 12.169] from FGE.74Rev3, which is a representative for the group of 
tertiary monothiols and therefore covers the seven substances [FL-no: 12.038, 12.085, 12.137, 12.138, 
12.145, 12.252 and 12.259] in this FGE. In addition, data on production volume and specification 
were submitted.  
Although the available data are limited the Panel considered that for the 44 substances in FGE.91Rev2 
the genotoxicity data do not preclude evaluating these substances through the Procedure. 
However, the Panel noted that candidate substance 3-(methylthio)heptenal [FL-no: 12.273] contains 5 
to 7 % of an α,β -unsaturated aldehyde, (2-(E)-heptenal [FL-no: 05.150], for which a concern has been 
raised due to the presence of a structural alert for genotoxicity. This substance is a candidate 
flavouring substance which is under evaluation in FGE.200Rev1 (FGE.19 subgroup 1.1.1). 
The Panel agrees with the JECFA that all substances can be evaluated through the Procedure. For 34 
substances the conclusion was that they do not pose a safety concern when used as flavouring 
substance at their estimated intake based on the MSDI approach. 
For 10 substances [FL-no: 12.038, 12.077, 12.085, 12.108, 12.137, 12.138, 12.145, 12.162, 12.252 
and 12.259] the Panel did not agree with the application of the Procedure by the JECFA for the 
following reasons: 
For the substances [FL-no: 12.077, 12.108 and 12.162], the JECFA has cleared by the JECFA at step 
B5 (the MSDI < 1.5 μg person per day). However, the Panel considers that adequate NOAELs exist to 
evaluate these substances and concluded at step B4 “No safety concern at the estimated levels of 
intake based on the MSDI approach”. 
For the tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259], contrary 
to the JECFA, the Panel concluded that there are no adequate NOAELs for these candidate substances 
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or from structurally related substances and that additional toxicity data are required to finalise the 
evaluation of these seven substances. 
For 34 substances, use levels have been provided by the Industry. The mTAMDI figures for five 
substances [FL-no: 12.264, 12.284, 12.274, 12.108 and 12.139] are above the threshold of concern for 
their structural classes. For these substances more reliable data are needed. On the basis of such data 
the flavouring substances should be reconsidered using the Procedure. For 10 substances [FL-no: 
12.038, 12.077, 12.085, 12.137, 12.138, 12.145, 12.162, 12.265, 12.267 and 17.036] for which use 
levels have not been provided, use levels are needed to calculate the mTAMDI values in order to 
identify those flavouring substances that need a more refined exposure assessment and to finalise the 
evaluation.  
In order to determine whether the conclusion for the 44 JECFA evaluated substances, for which the 
Panel concluded that they could be evaluated through the Procedure, can be applied to the materials of 
commerce, it is necessary to consider the available specifications. Specifications including complete 
purity criteria and identity are available for all 44 substances. 
Thus, for seven substances [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] 
evaluated through the Procedure, the Panel concluded that additional toxicity data are required.  
For candidate substance 3-(methylthio)heptenal [FL-no: 12.273], which contains 5 to7 %  of an α,β-
unsaturated aldehyde, 2-(E)-heptenal, with a possible genotoxic potential, the Panel cannot conclude 
that the material of commerce for this candidate substance is not of safety concern, until either this 
component is cleared with respect to a concern for genotoxicity, or this component is removed from 
the commercial product. 
For 36 substances [FL-no: 12.012, 12.017, 12.021, 12.077, 12.108, 12.126, 12.130, 12.134, 12.139, 
12.146, 12.153, 12.162, 12.240, 12.242, 12.243, 12.253, 12.254, 12.264, 12.265, 12.26712.274, 
12.275, 12.276, 12.284, 12.285, 12.286, 12.287, 12.288, 12.289, 12.290, 12.292, 12.293, 12.294, 
12.297, 15.049  and 17.036] the Panel agrees with the JECFA conclusion “No safety concern at 
estimated levels of intake as flavouring substances based on the MSDI approach.”. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 20084 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/20125. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/20006. 
EFSA has considered the Joint FAO/WHO Expert Committee on Food Additives (the JECFA) 
evaluation of 47 simple aliphatic and aromatic sulphides and thiols and tertiary thiols evaluated in the 
flavouring group evaluation 91 (FGE.91) and its latest revision. The opinion was adopted on 24 
November 2011. EFSA concluded in its opinion, contrary to the JECFA, that the seven tertiary thiols 
[FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] should not be evaluated using the 
Procedure due to concern for genotoxicity and, therefore, additional data was requested.  
Information on the representative material, 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] from 
FGE.74 was submitted by the European Flavour Association and forwarded by the Commission to 
EFSA on 26 April 2013. This information is intended to cover as well the re-evaluation of the 
following seven tertiary thiols from FGE.91: 
• 8-mercapto-p-menthan-3-one [FL-no: 12.038] 
• p-menth-1-ene-8-thiol [FL-no: 12.085] 
• 3-mercapto-3-methylbutan-1-ol [FL-no: 12.137] 
• 3-mercapto-3-methylbutyl formate [FL-no: 12.138] 
• 4-methoxy-2-methylbutane-2-thiol [FL-no: 12.145] 
• 4-mercapto-4-methyl-2-pentanol [FL-no: 12.252] 
• 1-mercapto-p-menthan-3-one [FL-no: 12.259] 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new 
information and, depending on the outcome, proceed to the full evaluation on these flavouring 
substances in accordance with Commission Regulation (EC) N° 1565/2000. 
 
 
 
 
 
 
                                                     
4  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and 
certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 
1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34-50. 
5  Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances 
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to 
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) 
No 1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p, 1-161. 
6  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8-16. 
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ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the “EFSA Procedure”. This Procedure 
is based on the Opinion of the Scientific Committee on Food (SCF, 1999), which has been derived 
from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999a), hereafter named the “JECFA 
Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be evaluated through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram (µg)/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Flavouring Group Evaluation 91 Revision 2 
 
EFSA Journal 2014;12(6):3707 8
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 µg per person per 
day would not be expected to present a safety concern. The Committee recommended that the 
Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be amended 
to include the last step on the right-hand side of the original procedure (“Do the condition of use result 
in an intake greater than 1.5 µg per day?”)” (JECFA, 1999a).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 µg per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro, 
will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
1. History of the Evaluation of the Substances in the Present FGE  
The EFSA consideration in FGE.91 dealt with 45 substances, forty simple aliphatic and aromatic 
sulphides and thiols evaluated by the JECFA at the 68th meeting, 2007 and five tertiary thiols 
evaluated by JECFA at the 53rd meeting, 1999. For seven tertiary thiols [FL-no: 12.038, 12.085, 
12.137, 12.138, 12.145, 12.252 and 12.259] adequate genotoxicity data were needed before the 
substances can be evaluated through the Procedure. 
The first revision of FGE.91, FGE.91Rev1, included the assessment of two additional substances, 
benzyl methyl sulphide [FL-no: 12.077] and methyl phenyl sulfide [FL-no: 12.162]. These substances 
were evaluated by the JECFA at the 53rd meeting in 1999. Furthermore, additional information had 
been submitted on stereoisomerism for [FL-no: 12.108, 12.264, 12.267, 12.273, 12.274, 12.284, 
12.285, 12.286, 12.287, 12.289, 12.290, 12.292, 12.297 and 15.049], on specifications for [FL no: 
12.038, 12.253, 12.256, 12.274, 12.276, 12.284 and 12.297] and on composition of mixture for [FL-
no: 12.153, 12.254, 12.256, 12.259] (EFFA, 2010; EFFA, 2011b). 
Since the publication of FGE.91Rev1, three of the 47 candidate substances are no longer supported by 
the Industry for use as flavouring substances in Europe (DG SANCO, 2013a). The three substances 
are diethyl trisulfide [FL-no: 12.114], ethyl propyl trisulfide [FL-no: 12.256] and propyl 
propanethiosulfonate [FL-no: 12.272] and they will therefore not be considered any further.  
FGE Opinion adopted Link No. of substances 
FGE.91 24 September 2009 http://www.efsa.europa.eu/en/efsajournal/pub/1337.htm 45 
FGE.91Rev1 23 November 2011 http://www.efsa.europa.eu/en/efsajournal/pub/2459.htm 47 
FGE.91Rev2   44 
Flavouring Group Evaluation 91 Revision 2 
 
EFSA Journal 2014;12(6):3707 9
The present revision of FGE.91, FGE.91Rev2 concerns the re-consideration of seven JECFA-
evaluated substances [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] 
considered in FGE.91 where the Panel concluded that the Procedure should not be applied until 
adequate genotoxicity data would be available. 
For 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] a bacterial reverse mutation assay has been 
provided (Mc Garry, 2012). This substance [FL-no: 12.169] from FGE.74Rev3 is considered a 
representative for tertiary monothiols in the Union List, i.e. [FL-no: 12.038, 12.085, 12.137, 12.138, 
12.145, 12.252 and 12.259] in the present FGE, [FL-no: 12.241] in FGE.74Rev3 and [FL-no: 12.304] 
in FGE.08Rev5. 
Since the publication of FGE.91Rev1 tonnage figures for seven substances [FL-no: 12.038, 12.085, 
12.137, 12.138, 12.145, 12.252 and 12.259] and additional information on specification for eight 
substances [FL-no: 12.085, 12.145, 12.162, 12.252, 12.259, 12.274, 12.284 and 15.049] have been 
provided by Industry (IOFI, 2012; EFFA, 2013). This new information is also included in the present 
revision of this FGE. 
2. Presentation of the Substances in the JECFA Flavouring Group 
2.1. Description 
2.1.1. JECFA Status 
The JECFA has evaluated a group of 51 flavouring substances consisting of simple aliphatic and 
aromatic sulphides and thiols at the 68th meeting (JECFA, 2008a). 
The JECFA has at the 53rd meeting, which was before 2000, evaluated a group of 137 flavouring 
substances consisting of simple aliphatic and aromatic sulphides and thiols with and without an 
additional oxygenated functional group (JECFA, 2000). 
2.1.2. EFSA Considerations 
This FGE only deals with 44 of the above mentioned 188 substances: 37 substances evaluated by the 
JECFA at the 68th meeting, 2007, and seven substances evaluated by JECFA at the 53rd meeting, 1999 
because: 
• Of the 51 simple aliphatic and aromatic sulphides and thiols evaluated by the JECFA at the 
68th meeting six are not in the Register (methionyl butyrate (JECFA-no: 1668), S-Ethyl 2-
acetylaminoethanethionate (JECFA-no: 1680), (±)-3-(Ethyl-thio)butanol (JECFA-no: 1703), 
(±)-3-mercapto-1-butyl acetate (JECFA-no: 1705), 3-mercapto-3-methyl-1-butyl acetate 
(JECFA-no: 1706), 2,5-dithiahexane (JECFA-no: 1707) and five substances have already been 
evaluated in FGE.08 [FL-no: 12.120, 12.165, 12.191, 12.199 and 12.214]. The remaining 40 
substances from the 68th meeting were considered in FGE.91 and FGE.91Rev1. Since the 
publication of FGE.91Rev1, three of the 40 candidate substances are no longer supported for 
use as flavouring substances in Europe by Industry (DG SANCO, 2013a). Accordingly only 
37 substances from this JECFA group are considered in revision of FGE.91 (FGE.91Rev2). 
• Of the 137 simple aliphatic and aromatic sulphides and thiols with and without an additional 
oxygenated functional group evaluated by the JECFA at the 53rd meeting five are tertiary 
thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145] used as supporting substances in 
FGE.08 and following revisions. These substances were evaluated by the JECFA before the 
year 2000. For flavouring substances evaluated by the JECFA before 2000 it is laid down in 
Commission Regulation (EC) No 1565/2000 (EC, 2000) that if they are considered acceptable, 
at the estimated levels of intake, by the JECFA and comply with the general use criteria, they 
could be included in the list of authorised substances without undergoing a separate evaluation 
for the time being. However, in FGE.08Rev1 the genotoxicity issues that were noted for 
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candidate tertiary thiols are obviously also of relevance for the five supporting JECFA-
evaluated tertiary thiols in FGE.08Rev1. Furthermore, two of the 137 substances are acyclic 
sulphides [FL-no: 12.077 and 12.162], which the JECFA evaluated at step B5; No NOAEL 
exists to provide a margin of safety, but as the estimated intake in the USA of 0.02 and 0.4 
µg/capita/day, respectively, are below the threshold of concern of 1.5 µg/person/day the 
JECFA Committee would not expect the two substances to present a safety concern when used 
as flavouring substances. However, in line with the opinion expressed by the Scientific 
Committee on Food (SCF, 1999), the Panel does not make use of this threshold of 1.5 
µg/person/day. Accordingly, these seven substances (i.e. 5 tertiary thiols and two sulphides) 
from the 53rd meeting are also considered. 
The Panel concluded that the substances in the JECFA flavouring groups of simple aliphatic and 
aromatic sulphides and thiols with and without an additional oxygenated functional group are 
structurally related to the group of aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or 
without additional oxygenated functional groups evaluated by EFSA FGE.08Rev5. 
The substances in FGE.08 and the following revisions were divided into subgroups. The 44 JECFA 
evaluated substances considered here, have been assigned to the following six EFSA defined 
subgroups:  
I Acyclic sulphides 
III Monothiols, including tertiary monothiols 
IV Dithiols 
V Acyclic and cyclic disulphides 
VII Mono-, di-, tri- and polysulphides with thioacetal structure 
VIII Thioesters 
None of the substances in the current FGE are related to subgroup II, VI, IX, X and XI from 
FGE.08Rev5.  
2.2. Isomers 
2.2.1. Status 
The following 21 substances [FL-no: 12.038, 12.085, 12.108, 12.252, 12.259, 12.264, 12.267, 12.273, 
12.274, 12.276, 12.284, 12.285, 12.286, 12.287, 12.288, 12.289, 12.290, 12.292, 12.297, 15.049 and 
17.036] in the group of JECFA evaluated simple aliphatic and aromatic sulphides and thiols have a 
chiral centre. Furthermore one substance [FL-no: 12.265] can exist as geometrical isomers. 
2.2.2. EFSA Considerations 
Adequate information on the isomeric composition is available for all of these 21 substances (Table 1). 
2.3. Specifications 
2.3.1. Status 
The European Flavour Industry has submitted specifications for the substances commercially used in 
Europe (EFFA, 2004; EFFA, 2006; EFFA, 2010; EFFA, 2011b; Flavour Industry, 2004; Flavour 
Industry, 2005; Flavour Industry, 2006; Flavour Industry, 2007a; Flavour Industry, 2007b). Although 
the JECFA specifications are available, the specifications used in this consideration are those 
submitted by the Industry for the 37 substances considered by the JECFA at the 68th meeting. For the 
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remaining seven substances (from 53rd meeting) the JECFA specifications are used (JECFA, 1999b). 
See Table 1.  
2.3.2. EFSA Considerations 
Specifications including complete purity criteria and identity tests are available for all 44 substances.. 
The Panel noted that candidate substance 3-(methylthio)heptenal [FL-no: 12.273] may contain up to 5-
7 % of an α,β-unsaturated aldehyde 2-(E)-heptenal [FL-no: 05.150]. 
3. Intake Estimation 
3.1. Status 
For all substances evaluated through the JECFA Procedure production volumes, based on which 
MSDI values can be calculated, are available for EU (JECFA, 2008a; EFFA, 2011a; IOFI, 2012) (see 
Table 7). 
3.2. EFSA Considerations 
Of the in total 44 substances evaluated through the JECFA Procedure, 39 substances have intake data 
for the EU available from the JECFA evaluation (JECFA, 2008a; EFFA, 2011a) and for five 
substances [FL-no: 12.137, 12.138, 12.145, 12.284 and 17.036] the Industry has submitted production 
figures for EU to EFSA. These data have been used in the present consideration (see Appendix A, 
Table A.2 and Table 7). 
For 34 substances normal and maximum use levels have been provided by the Flavour Industry 
(EFFA, 2004; EFFA, 2006; Flavour Industry, 2004; Flavour Industry, 2005; Flavour Industry, 2006; 
Flavour Industry, 2007a) in accordance with the Commission Regulation (EC) No 1565/2000 (EC, 
2000) (see Appendix A, Table A.1). Based on the normal use levels, mTAMDI figures can be 
calculated (for calculation of mTAMDI figures, see e.g. Annex II in (EFSA, 2004).  
The mTAMDI figures calculated for five substances [FL-no: 12.264, 12.284, 12.274, 12.108 and 
12.139] are above the threshold of concern for their structural classes (see Appendix A, Table A.1). 
For these substances more reliable data are needed. On the basis of such data the flavouring substances 
should be reconsidered using the Procedure. For 10 substances [FL-no: 12.038, 12.077, 12.085, 
12.137, 12.138, 12.145, 12.162, 12.265, 12.267 and 17.036] use levels are still needed to calculate the 
mTAMDI values in order to identify those flavouring substances that need a more refined exposure 
assessment and to finalise the evaluation. 
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SUMMARY OF SPECIFICATION DATA 
Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
12.012 
1699 
Diethyl disulfide 
S
S
 
 
533 
110-81-6 
Liquid 
C4H10S2 
122.24 
Practically 
insoluble or 
insoluble 
Soluble 
152 
 
IR MS 
95 % 
1.502-1.508 
0.990-0.996 
 
(EFFA, 2004). 
12.017 
1659 
Ethanethiol SH   546 
75-08-1 
Liquid 
C2H6S 
62.13 
Slightly 
soluble 
Soluble 
35 
 
IR NMR MS 
95 % 
1.425-1.431 
0.833-0.839 
 
(EFFA, 2004). 
12.021 
1700 
Allyl propyl disulfide 
S
S
 
4073 
600 
2179-59-1 
Liquid 
C6H12S2 
148.28 
Practically 
insoluble or 
insoluble 
Soluble 
66 (13 hPa) 
 
NMR MS 
95 % 
1.497-1.517 
0.999-1.005 
 
(EFFA, 2004). 
12.038 
561 
8-Mercapto-p-menthan-
3-one 
O
SH
3177 
11789 
38462-22-5 
Liquid 
C10H18OS 
186.31 
Insoluble 
Soluble 
120 (13 hPa) 
 
IR 
97 % 
1.492-1.509 
0.995-1.010 
 
(JECFA, 1999b). Mixture of four 
diastereoisomers, each about 25 % 
(EFFA, 2014). 
12.077 
460 
Benzyl methyl sulfide 
S
 
3597 
 
766-92-7 
Liquid 
C8H10S 
138.23 
Slightly 
soluble 
Soluble 
197 
 
IR 
98 % 
1.563-1.573 
1.015-1.020 
 
(JECFA, 1999b; EFFA, 2011b). 
12.085 
523 
p-Menth-1-ene-8-thiol 
SH
 
3700 
 
71159-90-5 
Liquid 
C10H18S 
170.31 
Slightly 
soluble 
Soluble 
58 (0.4 hPa) 
 
IR 
98 % 
1.504 
0.948 (20°) 
 
(JECFA, 1999b). Racemate (EFFA, 
2014). 
12.108 
1672 
Di-isopentyl thiomalate 
 
 
11454 
68084-03-7 
Solid 
C14H26O4S 
290.42 
Practically 
insoluble or 
insoluble 
Soluble 
425 
50 
NMR MS 
95 % 
n.a. 
n.a. 
 
Specifications (EFFA, 2004). 
Racemate (EFFA, 2010). 
12.114 Diethyl trisulfide 
S
S
S
4029 Liquid Practically 217 1.556-1.560  
O
O
O
SH O
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
1701 11451 
3600-24-6 
C4H10S3 
154.3 
insoluble or 
insoluble 
Soluble 
 
NMR MS 
95 % 
1.121-1.231 (EFFA, 2006). 
12.126 
1694 
Ethyl propyl disulfide 
S
S
 
4041 
11478 
30453-31-7 
Liquid 
C5H12S2 
136.27 
Practically 
insoluble or 
insoluble 
Soluble 
180 
 
IR NMR MS 
95 % 
1.483-1.493 
0.943-0.953 
 
(EFFA, 2006). 
12.130 
1663 
Heptane-1-thiol SH  4259 11485 
1639-09-4 
Liquid 
C7H16S 
132.26 
Practically 
insoluble or 
insoluble 
Soluble 
175 
 
IR NMR MS 
95 % 
1.497-1.503 
0.840-.0846 
 
(EFFA, 2004). 
12.134 
1679 
S-Isopropyl 3-methylbut-
2-enethioate 
S
O
 
4260 
 
34365-79-2 
Liquid 
C8H14OS 
158.26 
Practically 
insoluble or 
insoluble 
Soluble 
236 
 
NMR 
95 % 
1.486-1.492 
1.006-1.012 
 
(EFFA, 2004). 
12.137 
544 
3-Mercapto-3-
methylbutan-1-ol 
HO
SH  
3854 
 
34300-94-2 
Liquid 
C5H12OS 
120.2 
Soluble 
Soluble 
186 (950 hPa) 
 
NMR MS 
96 % 
1.480-1.490 
0.989 (20°) 
 
(JECFA, 1999b). 
12.138 
549 
3-Mercapto-3-
methylbutyl formate 
O O
SH  
3855 
 
50746-10-6 
Liquid 
C6H12O2S 
148.22 
Soluble 
Soluble 
181 
 
IR 
95 % 
1.462-1.472 
1.03 
 
(JECFA, 1999b). 
12.139 
1666 
2-Mercaptoanisole 
SH
O
4159 
11880 
7217-59-6 
Liquid 
C7H8OS 
140.2 
Practically 
insoluble or 
insoluble 
Soluble 
227 
 
IR NMR MS 
95 % 
1.589-1.595 
1.137-1.149 
 
(EFFA, 2006). 
12.145 
548 
4-Methoxy-2-
methylbutane-2-thiol 
SH
O  
3785 
 
94087-83-9 
Liquid 
C6H14OS 
134.24 
Insoluble 
Soluble 
59 
 
IR 
98 % 
1.445-1.455 
0.907-0.923 
 
(JECFA, 1999b). 
12.146 
1691 
Methyl 
(methylthio)acetate 
S
O
O 4003 
11525 
16630-66-3 
Liquid 
C4H8O2S 
120.2 
Practically 
insoluble or 
insoluble 
145 
 
IR NMR MS 
1.464-1.466 
1.105-1.115 
 
(EFFA, 2006). 
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
Soluble 98 % 
12.153 
1693 
Methyl ethyl disulfide S
S  
4040 
11470 
20333-39-5 
Liquid 
C3H8S2 
108.22 
Practically 
insoluble or 
insoluble 
Soluble 
137 
 
IR NMR MS 
80 % 
1.410-1.418 
1.015-1.029 
 
Min. Assay value 80 %. Secondary 
components are 7-8 % diethyl 
sulfide and 8-10 % dimethyl 
sulfide. (EFFA, 2006; EFFA, 
2011b).  
12.162 
459 
Methyl phenyl sulfide 
S
3873 
11533 
100-68-5 
Liquid 
C7H8S 
124.21 
Insoluble 
Soluble 
188-193 
 
IR 
98 % 
1.532-1.551 
0.958-0.968 
 
(JECFA, 1999b; EFFA, 2011b). 
12.240 
1684 
2,4,6-Trithiaheptane SSS  4214  
6540-86-9 
Liquid 
C4H10S3 
154.32 
Slightly 
soluble 
Soluble 
255 
 
IR NMR MS 
95 % 
1.444-1.445 
1.540-1.550 
 
(EFFA, 2006). 
12.242 
1675 
Methylthiomethylmercap
tan 
SHS
 4185  
29414-47-9 
Liquid 
C2H6S2 
94.2 
Soluble 
Soluble 
40 (2.7 hPa) 
 
NMR 
97 % 
1.552-1.556 
1.040-1.046 
 
(EFFA, 2006). 
12.243 
1661 
Dimercaptomethane HS SH  4097  
6725-64-0 
Liquid 
CH4S2 
80.17 
Soluble 
Soluble 
118 
 
NMR 
95 % 
1.578-1.584 
0.827-0.831 
 
(EFFA, 2006). 
12.252 
1669 
4-Mercapto-4-methyl-2-
pentanol 
OH
SH
4158 
 
31539-84-1 
Liquid 
C6H14OS 
134.26 
Soluble 
Soluble 
51 (0.1 hPa) 
 
NMR 
98 % 
1.463-1.468 
1.154-1.158 
 
(EFFA, 2006). Racemate (59-60 % 
trans and 29-30 % cis) (EFFA, 
2013). 
12.253 
1697 
Amyl methyl disulfide 
S
S
 
4025 
 
72437-68-4 
Liquid 
C6H14S2 
150.31 
Practically 
insoluble or 
insoluble 
Soluble 
198-202 
 
IR NMR MS 
97 % 
1.485-1.495 
0.943-0.953 
 
Specifications (EFFA, 2006). 
Minimum assay (97 %) (EFFA, 
2010). 
12.254 
1698 
Butyl ethyl disulfide S
S  
4027 
 
63986-03-8 
Liquid 
C6H14S2 
150.31 
Practically 
insoluble or 
insoluble 
Soluble 
202 
 
IR NMR MS 
90 % 
1.492-1.502 
0.950-0.968 
 
Minimum assay (90 %). Secondary 
components diethyl disulfide (2-3 
%) and dibutyl disulfide (5-6 %), 
(EFFA, 2010; EFFA, 2006). 
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
12.256 
1695 
Ethyl propyl trisulfide S
S
S
 
4042 
 
31499-70-4 
Liquid 
C5H12S3 
168.34 
Practically 
insoluble or 
insoluble 
Soluble 
234-237 
 
IR NMR MS 
98 % 
1.549-1.559 
1.070-1.087 
 
Minimum assay (98 %). Secondary 
components diethyl trisulfide (20-
30 %) and dipropyl trisulfide (20-
30 %), (EFFA, 2010; EFFA, 2006). 
12.259 
1673 
1-Mercapto-p-menthan-
3-one 
O
HS
 
4300 
 
29725-66-4 
Liquid 
C10H18OS 
186.31 
Practically 
insoluble or 
insoluble 
Soluble 
122 (1.3 hPa) 
 
NMR 
89 % 
1.487-1.497 
0.989-0.999 
 
Minimum assay (89 %) (EFFA, 
2006). Cis- and trans-Mercapto-p-
menthan-3-one, two cis- and two 
trans-enantiomers (each 25 %) 
Secondary components are 
piperitone (8-9 %) and alpha-
terpineol (1-2 %). (EFFA, 2013). 
12.264 
1670 
4,2-Thiopentanone SH O
 
4157 
 
92585-08-5 
Liquid 
C5H10OS 
118.00 
Insoluble 
Soluble 
258-260 
 
IR NMR MS 
95 % 
1.437-1.443 
1.154-1.158 
 
Specifications (Flavour Industry, 
2006). Racemate (EFFA, 2010). 
12.265 
1683 
2-Methyl-1-methylthio-
2-butene S
 
4173 
 
89534-74-7 
Liquid 
C6H12S 
116.23 
Very slightly 
soluble 
Soluble 
78 (100hPa) 
 
IR NMR MS 
99.3 % 
1.471 
0.861 
 
Industry has informed: 99.3 % (E)-
isomer, 0.2 % (Z)-isomer, 0.2 % 1-
methylthio-2-propanone, 0.1 % 
methyl 2-methyl-2-butenoate, 0.2 
% unknown. 
Register name to be changed to 
(E)-2-Methyl-1-methylthio-2-
butene (Flavour Industry, 2007b).  
12.267 
1667 
Propyl-2-
mercaptopropionate 
O
O
SH 4207 
 
19788-50-2 
Liquid 
C6H12O2S 
148.23 
Very slightly 
soluble 
Soluble 
193 
 
IR NMR MS 
97.3 % 
1.4497 
1.018 
 
Specifications (Flavour Industry, 
2007b). Racemate (EFFA, 2010). 
12.272 
1702 
Propyl 
propanethiosulfonate 
S
S
O
O 4263 
 
1113-13-9 
Liquid 
C6H14O2S2 
182.31 
Sparingly 
soluble 
Soluble 
113 
 
IR NMR MS 
95 % 
1.485 
1.121 
 
No longer supported by Industry 
(DG SANCO, 2013b). (Flavour 
Industry, 2007b). 
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
12.273 
1692 
3-(Methyl thio)heptanal 
S
O  
4183 
 
51755-70-5 
Liquid 
C8H16OS 
160.28 
Insoluble 
Soluble 
95-96 
 
IR NMR MS 
92 % 
1.469-1.475 
0.943-0.947 
 
Specifications (Flavour Industry, 
2006). Register name to be changed 
to 3-(Methyl thio)heptanal. 
Racemate. Minimum assay (92 %). 
2-(E)-heptenal (5-7 %) (EFFA, 
2010). 
12.274 
1687 
3,6-Diethyl-1,2,4,5-
tetrathiane and 3,5-
diethyl-1,2,4-trithiolane 
mix in vegetable oil 
triglycerides 
S
S
S
SS
S S  
4094 
 
 
Liquid 
C6H12S4/C6H12
S3 
212.43 
Insoluble 
Soluble 
64-70 (1.3 hPa) 
 
NMR MS 
95 % (1 % sol.) 
1.447-1.453 
0.948-0.952 
 
Mixture of 3,6-diethyl-1,2,4,5-
tetrathiane (55-60 %) (CASrn 
54717-12-3) [FL-no: 15.049] and 
3,5-diethyl-1,2,4-trithiolane (25-40 
%) (CASrn 54644-28-9) (EFFA, 
2013). Molecular weight: 
212.43/180.36 (Flavour Industry, 
2006). Mixture of three diastereo-
isomers (EFFA, 2010). Due to the 
symmetry there is one meso-form 
(cis-form) and two trans-forms. 
12.275 
1681 
Allylthio hexanoate 
S
O
 
4076 
 
156420-69-8 
Liquid 
C9H16OS 
172.29 
Insoluble 
Soluble 
195-196 
 
IR NMR MS 
98 % 
1.473-1.479 
0.930-0.934 
 
(Flavour Industry, 2006). 
12.276 
1671 
(S)-1-Methoxy-3-
heptanethiol 
SH
O  
4162 
 
400052-49-5 
Liquid 
C8H18OS 
162.30 
Slightly 
soluble 
Soluble 
203.8 
 
IR NMR MS 
99 % 
1.456-1.457 
0.908-0.908 
 
(Flavour Industry, 2007a; EFFA, 
2011b). 
12.284 
1709 
bis(1-
Mercaptopropyl)sulphide 
S
SHSH
 
 
 
53897-60-2 
Liquid 
C6H14S3 
182 
Insoluble 
Soluble 
225-
226(101hPa) 
 
IR NMR 
> 98 % 
1.542-1.552 
1.077-1.087 
 
Specifications (Flavour Industry, 
2004).Mixture of diastereo-isomers 
(EFFA, 2010). Due to the 
symmetry there is one meso-form 
(50 %) and two other 
distereoisomers (25 % each) 
(EFFA, 2013). 
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
12.285 
1688 
3-Methylthio-2-butanone 
S
O  
 
53475-15-3 
Liquid 
C5H10OS 
118.2 
Slightly 
soluble 
Soluble 
160 
 
IR NMR 
97 % 
1.468-1.4774 
0.992-0.998 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.286 
1689 
4-Methylthio-2-
pentanone 
O
S  
 
 
143764-28-7 
Liquid 
C6H12OS 
132.22 
Very slightly 
soluble 
Soluble 
183 
 
NMR MS 
98 % 
1.468-1.472 
0.969-0.979 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.287 
1690 
Methyl 3-
(methylthio)butanoate S
O
O
4166 
 
207983-28-6 
Liquid 
C6H12O2S 
148.22 
Very slightly 
soluble 
Soluble 
193 
 
NMR 
98 % 
1.459-1.465 
1.034-1.040 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.288 
1664 
Heptan-2-thiol SH
 
 
 
628-00-2 
Liquid 
C7H16S 
132.27 
Slightly 
soluble 
Soluble 
164 
 
NMR 
98 % 
1.442-1.448 
0.832-0.838 
 
Racemate (Flavour Industry, 2005). 
12.289 
1665 
1-Phenylethylmercaptan HS
 
 
 
6263-65-6 
Liquid 
C8H10S 
138.23 
Practically 
insoluble or 
insoluble 
Soluble 
199 
 
NMR MS 
98 % 
1.552-1.558 
1.001-1.007 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.290 
1674 
Methyl-3-
mercaptobutanoate 
O
SH O
 
4167 
 
54051-19-3 
Liquid 
C5H10O2S 
134.20 
Practically 
insoluble or 
insoluble 
Soluble 
172 
 
NMR 
98.5 % 
1.451-1.461 
1.052-1.058 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.292 
1704 
Hexyl 3-
mercaptobutanoate 
O
SH O
 
4136 
 
796857-79-9 
Liquid 
C10H20O2S 
204.33 
Practically 
insoluble or 
insoluble 
Soluble 
268 
 
NMR 
98 % 
1.459-1.465 
0.949-0.955 
 
Specifications (Flavour Industry, 
2005). Racemate (EFFA, 2010). 
12.293 
1660 
Ethane-1,1-dithiol 
HS
SH
 
 
 
69382-62-3 
Liquid 
C2H6S2 
94.2 
Soluble 
Soluble 
Distils: 71-78 
 
NMR 
99 % 
1.369-1.375 
0.829-0.833 
 
Product is a 1 % solution of ethane-
1,1-dithiol, purity 99 % min, in 
ethanol. 
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Table 1:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, 
°C (c) 
Melting point, 
°C 
ID test 
Assay 
minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments /  
Reference for specifications 
12.294 
1696 
Isopentyl methyl 
disulfide S
S  
4168 
 
72437-56-0 
Liquid 
C6H14S2 
150.31 
Practically 
insoluble or 
insoluble 
Soluble 
184-200 
 
NMR 
95 % 
1.516-1.522 
0.995-1.001 
 
(Flavour Industry, 2005). 
12.297 
1708 
3-Mercaptoheptyl acetate 
O
O
SH  
4289 
 
548774-80-7 
Liquid 
C9H18O2S 
190.30 
Slightly 
soluble 
Soluble 
242 
 
IR NMR MS 
99.9 % 
1.4605-1.4607 
0.9826-0.9830 
 
Specifications (Flavour Industry, 
2007b; EFFA, 2011b). Racemate 
(EFFA, 2010). 
15.049 
1686 
3,5-Diethyl-1,2,4-
trithiolane 
S
S
S  
4030 
 
54644-28-9 
Liquid 
C6H12S3 
180.35 
Practically 
insoluble or 
insoluble 
Soluble 
77 (0.1 hPa) 
 
NMR 
95 % 
1.558-1.570 
1.147-1.160 
 
Specifications (EFFA, 2006). 
Mixture of three diastereo-isomers 
(EFFA, 2010). Due to the 
symmetry there is one meso-form 
(cis-form (50 %)) and two trans-
forms (25 % each) (EFFA, 2013). 
17.036 
1710 
S-allyl-L-cysteine NH2
SHO
O
4322 
 
21593-77-1 
Solid 
C6H11NOS 
161.22 
Moderate 
soluble 
Slightly 
soluble 
 
214-216 
IR NMR MS 
95 % 
1.542 
1.191 
 
(Flavour Industry, 2007b). 
(a): Solubility in water, if not otherwise stated. 
(b): Solubility in 95 % ethanol, if not otherwise stated. 
(c): At 1013.25 hPa, if not otherwise stated. 
(d): At 20°C, if not otherwise stated. 
(e): At 25°C, if not otherwise stated. 
n.a., not available 
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4. Genotoxicity Data 
4.1. Genotoxicity Studies – Text Taken7 from the JECFA (JECFA, 2008a) 
In vitro 
No evidence of mutagenicity was observed when allylthio hexanoate [FL-no: 12.275], 3,6-diethyl-
1,2,4,5-tetrathiane [FL-no: 12.274] or allyl propyl disulfide [FL-no: 12.021] were incubated with 
Salmonella typhimurium strains TA97, TA98, TA100, TA102, TA1535 and/or TA1537 with and 
without metabolic activation at concentrations of up to 5000 µg/plate (Eder et al., 1980; Eder et al., 
1982b; King and Harnasch, 2002; Uhde, 2005; Zeiger et al., 1988). 
No evidence of mutagenicity was observed when the structurally related substances 
tetrahydrothiophene [FL-no: 15.102], 2-methylpropane-2-thiol [FL-no: 12.174] and methyl 
methanethiosulfonate [FL-no: 12.159] were incubated with S. typhimurium strains TA98, TA100, 
TA1535, TA1537, TA1538 and/or TA2637 with and without metabolic activation at concentrations of 
up to 10 000 µg/plate (Dorange et al., 1983; Pennwalt Corporation, 1987a; Phillips Petroleum 
Company, 1990a). 
Tetrahydrothiophene [FL-no: 15.102] tested negative in a cytogenetic assay with human lymphocytes, 
a mutation assay at the HPRT chromosome with Chinese hamster ovary (CHO) cells and an 
unscheduled deoxyribonucleic acid (DNA) synthesis test with human epithelial cells performed with 
and without metabolic activation at concentrations of up to 5120 µg/ml (Pennwalt Corporation, 
1987a). 
In the absence of an exogenous metabolic activation system, an increase was observed in the induction 
of forward mutations when L5178Ytk(+/–) mouse lymphoma cells were exposed to 2-methylpropane-
2-thiol [FL-no: 12.174] at the two highest tested concentrations (i.e. 202 and 1000 µg/ml); however, in 
the presence of such a system, 2-methylpropane-2-thiol yielded negative results at concentrations of 
up to 1000 µg/ml (Phillips Petroleum Company, 1990a). Mouse lymphoma assays conducted in the 
absence of metabolic activation for simple aliphatic and aromatic substances have been shown to be 
inconsistent with the results of other standardised genotoxicity assays. Moreover, culture conditions of 
low pH and high osmolality have been shown to produce false-positive results in in vitro genotoxicity 
assays (Cifone et al., 1987; Galloway et al., 1987; Heck et al., 1989). Therefore, it is not unexpected 
that other low molecular weight thiols (e.g. ethane thiol [FL-no: 12.017] and butane-1-thiol [FL-no: 
12.010]) have been shown to produce equivocal or positive evidence of mutagenicity in the mouse 
lymphoma forward mutation assay, while being negative in reverse mutation assays (Eder et al., 1980; 
Eder et al., 1982b; King and Harnasch, 2002; Uhde, 2005; Zeiger et al., 1988). Furthermore, dibutyl 
disulphide [FL-no: 12.111] yielded negative results in a mouse lymphoma forward mutation assay 
without metabolic activation; however, the concentrations tested in this trial were not specified 
(Dooley et al., 1987). 
Tetrahydrothiophene [FL-no: 15.102] and 2-methylpropane-2-thiol [FL-no: 12.174] were negative in a 
sister chromatid exchange (SCE) assay with CHO cells at concentrations of up to 125 and 1350 µg/ml, 
respectively, with and without metabolic activation (Pennwalt Corporation, 1987a; Phillips Petroleum 
Company, 1990a). Although a statistically significant increase in the number of SCEs was observed at 
concentrations of 450 and 1350 µg 2-methylpropane-2-thiol/ml, there was a lack of significant 
increases at lower test concentrations. Additionally, although statistically significant, the increases in 
SCEs were less than 2-fold greater than in controls. As such, the authors concluded 2-methylpropane-
2-thiol to be non-mutagenic (Phillips Petroleum Company, 1990a). 
                                                     
7  The text is taken verbatim from the indicated reference source, but text related to substances not included in the present
 FGE has been removed. 
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Methyl methanethiosulfonate [FL-no: 12.159] was negative in chromosomal aberration assays 
conducted in Saccharomyces cerevisiae strain D7 or S. cerevisiae haploid strain N123 at 
concentrations of up to 300 µg/ml (Dorange et al., 1983). 
Conclusion on genotoxicity 
The testing of these representative materials in vitro in prokaryotic and eukaryotic test systems 
indicates that this group of simple aliphatic and aromatic sulphides and thiols is not expected to exhibit 
any mutagenic or genotoxic properties. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA see Table 3. 
4.2. Genotoxicity Studies – Text Taken8 from EFSA FGE. 08Rev5 (EFSA CEF Panel, 2012) 
Only text from the relevant supporting subgroups (subgroup I, III, IV, V, VII and VIII) are shown 
here. 
In vitro / in vivo 
Genotoxicity in vitro data are available for four candidate substances: di-(1-propenyl)-sulfid (mixture) 
[FL-no: 12.298] (subgroup I); 2-methylpropane-2-thiol [FL-no: 12.174] (subgroup III); and dibutyl 
disulfide [FL-no: 12.111] (subgroup V). In addition studies are available on 12 supporting substances 
from subgroups I (1), III (4), IV (1), V (4) and VIII (2). 
In vivo data are available for three supporting substances from subgroups I (1), III (1) and V (1).  
Subgroup I (Acyclic sulphides) 
In vitro data are available for the candidate substance, di-(1-propenyl)-sulfide [FL-no: 12.298]; Ames 
test: S. typhimurium TA98, TA100, TA102, TA1535, TA1537, 1-100 microg/plate. Result was 
negative with and without metabolic activation (Stien, 2005). 
For supporting substances, only data on diallyl sulfide [FL-no: 12.088] are available: diallyl sulfide 
was negative in a limited bacterial reversion assay using one strain only (TA100) and provided 
equivocal results in an in vitro cytogenetic test in which increased incidences of cells with 
chromosomal aberrations and sister chromatid exchanges (SCEs), statistically significant but not dose 
related, were observed. In vivo diallyl sulfide was evaluated as negative in a micronucleus test in 
mouse bone marrow, which was, however, not designed to evaluate the genotoxicity of the substance 
itself as it was tested in a mixture. Overall the data available do not allow evaluation of the 
genotoxicity of the substances of this subgroup. 
Subgroup III (Monothiols)  
2-Methylpropane-2-thiol [FL-no: 12.174] is reported to be negative in an Ames test. It is reported to 
be positive in a mouse lymphoma assay without metabolic activation and negative in the test with 
metabolic activation, and it is reported to be negative in an in vitro SCE assay. However, these studies 
are reported only as summaries [Phillips Petroleum Company, 1990a]. Some details are available for 
methods but not for the results. Although the validity of these studies cannot be fully evaluated, the 
positive result in the mouse lymphoma assay raises concern with respect to the potential for 
genotoxicity of this tertiary thiol and structurally related compounds, i.e. 2-methylbutane-2-thiol [FL-
no: 12.172] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and the five supporting 
substances [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145].  
                                                     
8  The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. 
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The in vitro data available for the other substances in this subgroup do not provide indication of 
concern for genotoxicity. 
Subgroup IV (Dithiols) 
Equivocal results were reported for the only supporting substance tested. 1,2-ethanedithiol [FL-no: 
12.066] was evaluated positive for induction of gene mutations and SCEs in vitro in a poorly reported 
study. However, increased mutation frequencies were associated with unacceptably high toxicity, and 
the relevance of SCEs for genotoxicity assessment is unclear. Moreover, the validity of the latter data 
set is questionable, as the distinct effect of S9 on toxicity observed in the other mammalian cell 
mutation study was not replicated. 1,2-ethanedithiol [FL-no: 12.066] was reported in an abstract to be 
negative in the Ames test. 
Subgroup V (Acyclic and Cyclic dipolysulphides) 
Dibutyl disulfide [FL-no: 12.111] is reported to be negative in a mouse lymphoma assay (Dooley et 
al., 1987). However, the study is reported only as abstract, and thus, the validity cannot be evaluated.  
Further data are available for the supporting substances diallyl disulfide [FL-no: 12.008], 
dimethyldisulfide [FL-no: 12.026], phenyl disulfide [FL-no: 12.043] and benzyl disulfide [FL-no: 
12.081]. All substances were negative in the Ames test. In addition, diallyl disulfide was reported to be 
positive in a chromosomal aberration assay in vitro, with and without metabolic activation, and weakly 
positive in a SCE assay. However, the validity of these findings is doubtful as chromosomal 
aberrations were only increased in conditions associated with extensive (> 90 %) lethality, and 
because of the limitation of SCE in genotoxic hazard identification. 
Subgroup VII (Mono-, di-, tri- and polysulphides with thioacetal structure) 
There are no data available on genotoxicity for the substances in this group. However, one of the 
hydrolysis products of the candidate substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] is 
structurally related to the above-mentioned tertiary thiols, raising concern with respect to the 
genotoxicity of this candidate. Therefore, in the absence of further genotoxicity data, the Panel 
concluded that the Procedure could not be applied to 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057]. 
Subgroup VIII (Thioesters) 
The in vitro data available on supporting substances provide no indication of concern for genotoxicity. 
Conclusion on genotoxicity  
Most in vitro and in vivo studies are of limited or insufficient quality and provide only limited 
information.  
The available data raise concern with respect to genotoxicity of three tertiary thiols [FL-no: 12.172, 
12.174 and 12.304], included as candidate substances in subgroup III. Hydrolysis of the candidate 
substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], included in subgroup VII, leads to the 
formation of a tertiary thiol structurally related to the above-mentioned compounds. Therefore, there is 
also concern with respect to genotoxicity of this candidate substance. The Panel noted that in FGE.08 
five of the supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 
12.145] for which a concern for genotoxicity has been raised in the FGE.08Rev1. These supporting 
substances have been evaluated by the JECFA at the 53rd meeting (JECFA, 2000b; JECFA, 2000). 
These supporting substances have been considered by EFSA in FGE.91 (EFSA CEF Panel, 2010q). 
In addition, genotoxicity of the candidate substance methyl methanethiosulphonate [FL-no: 12.159], 
included in subgroup X, could not be assessed from the data available. However, due to the similarity 
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with methyl methanesulphonate, a direct acting mutagen and carcinogen, there is concern with respect 
to genotoxic potential of this candidate substance.  
Therefore, the Panel decided that the Procedure could not be applied to the candidate substances [FL-
no: 12.159, 12.172, 12.174, 12.304 and 16.057] until adequate in vivo genotoxicity data become 
available. 
The other in vitro/in vivo genotoxicity data available, often from limited or poorly reported studies, do 
not provide clear indication of concern for genotoxicity for the remaining candidate substances 
included in the present evaluation. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA in FGE.08Rev5, see Table 4 
and Table 5. 
4.3. EFSA Considerations  
Subgroup III includes the tertiary thiols for which a genotoxicity concern was established based on 
data from a limited gene mutation assay for candidate substances FGE.08Rev1 [FL-no: 12.174] and 
additional genotoxicity data were requested for this group of substances. Since the publication of the 
latest revision of FGE.08, FGE.08Rev5 the Industry has submitted a new bacterial mutation assay for 
the tertiary thiol [FL-no: 12.169] included in FGE.91. This substance is considered by the Panel to be 
representative for the whole group of tertiary thiols (in FGE.08, FGE.74 and FGE.91). Based on the 
new genotoxicity data the Panel concluded that 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] was 
not genotoxic in the assay and that 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] does no longer 
give rise to concern with respect to gene mutations. The Panel therefore concluded that the tertiary 
thiols, including the substances in FGE.91Rev2 [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 
12.252 and 12.259] can be evaluated using the Procedure. 
Although the available data are limited9 the Panel considered that for the 44 substances in 
FGE.91Rev2 the genotoxicity data do not preclude evaluating these substances through the Procedure. 
However, the Panel noted that candidate substance 3-(methylthio)heptenal [FL-no: 12.273] may 
contain up to 5-7 % of an α,β -unsaturated aldehyde (2-(E)-heptenal [FL-no: 05.150] for which a 
concern has been raised due to the presence of a structural alert for genotoxicity. This substance is a 
candidate flavouring substance [FL-no: 05.150] which is under evaluation in FGE.200Rev1 (FGE.19 
subgroup 1.1.1). 
5. Application of the Procedure 
5.1. Application of the Procedure to Simple Aliphatic and Aromatic Sulphides and Thiols 
by the JECFA (JECFA, 2000; JECFA, 2008a) 
Note: The JECFA evaluated substances not in the Register, are identified by their four digit JECFA 
number in the following text. 
Step 1 
In applying the Procedure for the Safety Evaluation of Flavouring Agents to these 44 flavouring 
agents considered in this FGE, the Committee assigned 31 [FL-no: 12.012, 12.017, , 12.126, 12.130, 
12.134, 12.137, 12.138, 12.145, 12.146, 12.153, 12.240, 12.242, 12.243, 12.252, 12.253, 12.254, 
12.264, 12.265, 12.267, 12.273, 12.276, 12.284, 12.285, 12.286, 12.287, 12.288, 12,290, 12.292, 
12.293, 12.294 and 12.297] to structural class I and 10 [FL-no: 12.021, 12.038, 12.077, 12.085, 
12.162, 12.259, 12.274, 12.275, 12.289 and 15.049] to structural class II. The remaining three 
                                                     
9  The Panel noted that few days before the adoption of the Opinion EFFA provided a new in vivo micronucleus  
 study on [FL-no:12.169] which will be considered in the next revision of this Opinion 
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flavouring agents [FL-no: 12.108, 12.139 and 17.036] were assigned to structural class III (Cramer et 
al., 1978). 
Step 2 
None of the flavouring agents in this group can be predicted to be metabolised to innocuous products. 
The evaluation of these substances therefore proceeded via the B-side of the Procedure.  
Step B3  
The estimated daily per capita intakes of the 31 flavouring agents in this group in structural class I are 
below the threshold of concern (i.e. 1800 µg/person per day for class I). The estimated daily per capita 
intakes of the 10 flavouring agents in structural class II are below the threshold of concern (i.e. 540 
µg/person per day for class II). The estimated daily per capita intakes of the three flavouring agents in 
structural class III are below the threshold of concern (i.e. 90 µg/person per day for class III). 
Accordingly, the evaluation of all the substances in the group proceeded to Step B4.  
Step B4  
For 2-methyl-1-methylthio-2-butene [FL-no: 12.265], the no-observed effect level (NOEL) of 250 
mg/kg body weight (bw) per day for the structurally related substance methyl sulfide [FL-no: 12.006] 
from a 98-day study in male and female rats (Butterworth et al., 1975) provides an adequate margin of 
safety (at least 125 million) in relation to currently estimated levels of intake of this substance from its 
use as a flavouring substance. This NOEL is also appropriate for the structurally related substances 
2,4,6-trithiaheptane [FL-no: 12.240] and 2,5-dithiahexane (No. 1707), because they are all simple 
sulfides that are anticipated to undergo oxidation and subsequent metabolism via similar metabolic 
pathways. In relation to the currently estimated levels of intake from use as flavouring substances, the 
NOEL of 250 mg/kg bw per day provides adequate margins of safety of > 1 billion10and 125 million 
for 2,4,6-trithiaheptane [FL-no: 12.240] and 2,5-dithiahexane (No. 1707), respectively.  
For methionyl butyrate (No. 1668), the NOEL of 1.4 mg/kg bw per day for the structurally related 
substance 2-(methylthiomethyl)-3-phenylpropenal [FL-no: 12.087] from a 92-day study in male rats 
(Cox et al., 1979) provides an adequate margin of safety (7 million) in relation to currently estimated 
levels of intake of this substance from its use as a flavouring substance. This NOEL is also appropriate 
for the structurally related substances (±)-isobutyl 3-methylthiobutyrate [FL-no: 12.214], methyl 
(methylthio)acetate [FL-no: 12.146] and (±)-3-(methylthio)heptanal [FL-no: 12.273], because they are 
all acyclic sulfides with oxidized sidechains. For these structurally related substances, the NOEL of 
1.4 mg/ kg bw per day provides adequate margins of safety in the range of 28 000 to 7 million in 
relation to the currently estimated levels of intake from use as flavouring agents.  
For methylthiomethylmercaptan [FL-no: 12.242], the NOEL of 0.3 mg/kg bw per day for the 
structurally related substance 3-methyl-1,2,4-trithiane [FL-no: 15.036] from a 90-day study in rats 
(Mondino, 1981) provides an adequate margin of safety (at least 150 000) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent.  
For 3-(methylthio)-2-butanone [FL-no: 12.285] and (±)-3-(ethylthio)butanol (No. 1703), the NOEL of 
0.7 mg/kg bw per day for the structurally related substance 2-mercapto-3-butanol [FL-no: 12.024] 
from a 90-day study in rats (Cox et al., 1974a) provides adequate margins of safety (> 3 million and 
350 000, respectively) in relation to estimated levels of intake of these substances from their use as 
flavouring agents.  
For 4-(methylthio)-2-pentanone [FL-no: 12.286], the NOEL of 1.9 mg/kg bw per day for the 
structurally related substance 3-mercapto-2-pentanone [FL-no: 12.031] from a 90-day study in rats 
                                                     
10 Note that billion is defined as (10
9
). 
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(Morgareidge, 1971) provides an adequate margin of safety (> 9 million) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent. 
For methyl 3-(methylthio)butanoate [FL-no: 12.287], the NOEL of 6.5 mg/ kg bw per day for the 
structurally related substance ethyl thioacetate [FL-no: 12.018] from a 91-day study in rats 
(Shellenberger, 1970) provides an adequate margin of safety (> 32 million) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent. 
For S-allyl-L-cysteine [FL-no: 17.036], the NOEL of 250 mg/kg bw per day from a 28-day study in 
rats (Kodera et al., 2002) provides an adequate margin of safety (> 8 million) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent.  
For (±)-2,8-epithio-cis-p-menthane [FL-no: 12.120], the NOEL of 10 mg/kg bw per day in female rats 
from a 28-day study (Finlay, 2004) provides an adequate margin of safety (> 1 million) in relation to 
currently estimated levels of intake of this substance from use as a flavouring agent.  
For ethanethiol [FL-no: 12.017], the NOEL of 0.56 mg/kg bw per day for the structurally related 
substance cyclopentanethiol [FL-no: 12.029] from a 90-day study in male and female rats 
(Morgareidge and Oser, 1970a) provides an adequate margin of safety (at least 80 000) in relation to 
currently estimated levels of intake of this substance from use as a flavouring agent. This NOEL is 
also appropriate for the structurally related substances 1-pentanethiol [FL-no: 12.191], 1-heptanethiol 
[FL-no: 12.130] and 2-heptanethiol [FL-no: 12.288], because they are all simple thiols. For these 
structurally related substances, the NOEL of 0.56 mg/ kg bw per day provides adequate margins of 
safety in the range of > 100 000 to > 2 million in relation to the currently estimated levels of intake 
from use as flavouring agents.  
For (±)-1-phenylethylmercaptan [FL-no: 12.289], the NOEL of 0.43 mg/ kg bw per day for the 
structurally related substance 2,6-dimethylthiophenol [FL-no: 12.082] from a 90-day study in rats 
(Peano et al., 1981) provides an adequate margin of safety (> 2 million) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent.  
For propyl 2-mercaptopropionate [FL-no: 12.267], the NOEL of 0.7 mg/kg bw per day for the 
structurally related substance 2-mercapto-3-butanol [FL-no: 12.024] from a 90-day study in rats (Cox 
et al., 1974a) provides an adequate margin of safety (at least 350 000) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent. This NOEL is also 
appropriate for the structurally related substances (±)-4-mercapto-4-methyl-2-pentanol [FL-no: 
12.252], (S)-1-methoxy-3-heptanethiol [FL-no: 12.276], methyl 3-mercaptobutanoate [FL-no: 
12.290]), hexyl 3-mercaptobutanoate [FL-no: 12.292], (±)-3-mercapto-1-butyl acetate (No. 1705), 3-
mercapto-3-methyl-1-butyl acetate (No. 1706), 3-mercaptoheptyl acetate [FL-no: 12.297] and cis-and 
trans-mercapto-p-menthan-3-one [FL-no: 12.259], because they are all thiols with oxidized side-
chains. For these structurally related substances, the NOEL of 0.7 mg/kg bw per day provides 
adequate margins of safety in the range of > 23 000 to > 3 million in relation to the currently estimated 
intakes from use as flavouring agents. 
For 4-mercapto-2-pentanone [FL-no: 12.264], the NOEL of 1.9 mg/kg bw per day for the structurally 
related substance 3-mercapto-2-pentanone [FL-no: 12.031] from a 90-day study in rats (Morgareidge, 
1971) provides an adequate margin of safety (> 1 million) in relation to currently estimated levels of 
intake of this substance from use as a flavouring agent.  
For 2-mercaptoanisole [FL-no: 12.139], the NOEL of 0.51 mg/kg bw per day for the structurally 
related substance 2-mercaptomethylbenzene [FL-no: 12.027] from a 90-day study in rats (Posternak et 
al., 1969) provides an adequate margin of safety (at least 25 500) in relation to currently estimated 
levels of intake of this substance from use as a flavouring agent.  
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For ethane-1,1-dithiol [FL-no: 12.293], the NOEL of 125 mg/kg bw per day for one hydrolysis 
product, acetaldehyde [FL-no: 05.001], from a 28-day study in rats (Til et al., 1988) and the NOEL of 
6.5 mg/kg bw per day for the other hydrolysis product, hydrogen sulfide, from a 90-day inhalation 
study in rats (Chemical Industry Institute of Technology, 1983) provide adequate margins of safety 
(625 million and > 32 million, respectively) in relation to currently estimated levels of intake of this 
substance from use as a flavouring agent.  
For dimercaptomethane [FL-no: 12.243], the NOEL of 15 mg/kg bw per day for one hydrolysis 
product, formaldehyde, from a 2-year study in rats (Til et al., 1989) and the NOEL of 6.5 mg/kg bw 
per day for the other hydrolysis product, hydrogen sulfide, from a 90-day inhalation study in rats 
(Chemical Industry Institute of Technology, 1983) provide adequate margins of safety (75 million and 
> 32 million, respectively) in relation to currently estimated levels of intake of this substance from use 
as a flavouring agent.  
For bis(1-mercaptopropyl)sulfide [FL-no: 12.284], the NOEL of 0.7 mg/kg bw per day for the 
structurally related substance 2,3-butanedithiol [FL-no: 12.022] from a 90-day study in rats 
(Morgareidge, 1974) provides an adequate margin of safety (70 000) in relation to currently estimated 
levels of intake of this substance from use as a flavouring agent.  
For ethyl methyl disulfide [FL-no: 12.153], the NOEL of 7.3 mg/kg bw per day for the structurally 
related substance propyl disulfide [FL-no: 12.014] from a 90-day study in rats (Posternak et al., 1969) 
provides an adequate margin of safety (> 14 million) in relation to currently estimated levels of intake 
of this substance from use as a flavouring agent. This NOEL is also appropriate for the structurally 
related substances ethyl propyl disulfide [FL-no: 12.126], methyl isopentyl disulfide [FL-no: 12.294], 
amyl methyl disulfide [FL-no: 12.253], butyl ethyl disulfide [FL-no: 12.254] and diethyl disulfide 
[FL-no: 12.012], because they are all simple disulfides. For these structurally related substances, the 
NOEL of 7.3 mg/kg bw per day provides adequate margins of safety in the range of > 14 million to > 
36 million in relation to the currently estimated intakes of these substances from use as flavouring 
agents.  
For allyl propyl disulfide [FL-no: 12.021], the NOEL of 4.6 mg/kg bw per day for the structurally 
related substance diallyl trisulphide [FL-no: 12.009] from a 90-day study in rats (Morgareidge and 
Oser, 1970b) provides an adequate margin of safety (> 4 million) in relation to currently estimated 
levels of intake of this substance from use as a flavouring agent.  
For 3,5-diethyl-1,2,4-trithiolane [FL-no: 15.049], the NOEL of 1.9 mg/kg bw per day for the 
structurally related substance 3,5-dimethyl-1,2,4-trithiolane [FL-no: 15.025] from a 91-day study in 
rats (BIBRA, 1976) provides an adequate margin of safety (at least 190 000) in relation to currently 
estimated levels of intake of this substance from use as a flavouring agent.  
For the mixture of 3,6-diethyl-1,2,4,5-tetrathiane (approximately 55 %) and 3,5-diethyl-1,2,4-
trithiolane (approximately 45 %) [FL-no: 12.274], the NOEL of 0.3 mg/kg bw per day for the 
structurally related substance 3-methyl-1,2,4-trithiane [FL-no: 15.036] from a 90-day study in rats 
(Mondino, 1981) provides an adequate margin of safety (30 000) in relation to currently estimated 
levels of intake of this substance from use as a flavouring agent.  
For thioacetic acid [FL-no: 12.199], the NOEL of 6.5 mg/kg bw per day for the structurally related 
substance ethyl thioacetate [FL-no: 12.018] from a 91-day study in rats (Shellenberger, 1970) provides 
an adequate margin of safety (> 900 000) in relation to currently estimated levels of intake of this 
substance from use as a flavouring agent. This NOEL is also appropriate for the structurally related 
substances S-methyl propanethioate [FL-no: 12.165], S-isopropyl 3-methylbut-2-enethioate [FL-no: 
12.134], allylthio hexanoate [FL-no: 12.275] and S-ethyl 2-acetylamino ethan-ethioate (No. 1680), 
because they are all thioesters and related acids. For these structurally related substances, the NOEL of 
6.5 mg/kg bw per day provides adequate margins of safety in the range of > 3 million to > 32 million 
in relation to their currently estimated levels of intake from their use as flavouring agents.  
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For 1-p-menthene-8-thiol [FL-no: 12.085] a NOEL of 0.56 mg/kg bw per day was reported in a 90-day 
study in rats treated with cyclopentanethiol [FL-no: 12.029] only at that dose (Morgareidge and Oser, 
1970a). 
For the four thiols with oxygenated side-chains [FL-no: 12.038, 12.137, 12.138, 12.145], NOELs are 
available for three substances (1.9 mg/kg bw per day for 2-mercapto-3-butanol [FL-no: 12.024] 
(JECFA No. 546), 2.8 mg/kg bw per day for alpha-methyl-beta-hydroxypropyl alpha-methyl-beta-
mercaptopropyl sulfide [FL-no: 12.036] (JECFA No. 547), and 1.9 mg/kg bw per day for 3-mercapto-
2-pentanone [FL-no: 12.031] (JECFA No. 560)). These NOELs were considered to provide adequate 
safety margins for the flavouring agents in this subgroup. 
No adequate NOEL was available for benzyl methyl sulphide and methyl phenyl sulphide [FL-no: 
12.077 and 12.162] or a related substance, therefore no adequate margin of safety can be provided. 
Therefore evaluation of the substance proceeds with step B5. 
Step B5  
Three substances, diisopentyl thiomalate [FL-no: 12.108], ], benzyl methyl sulphide [FL-no: 12.077] 
and methyl phenyl sulphide [FL-no: 12.162] were evaluated at this step of the Procedure. The 
currently estimated daily per capita intakes of all three substances are below 1.5 µg/person per day in 
Europe. Applying the criteria for Step B5 outlined in Annex 5 of the evaluations published after its 
forty-ninth meeting, the Committee concluded that the use of these substances as flavouring agents at 
their currently estimated levels of intake poses no safety concern. 
The stepwise evaluations of the substances evaluated by the JECFA are summarised in Table 6. 
5.2. Application of the Procedure to Aliphatic and Alicyclic Mono-, Di-, Tri-, and 
Polysulphides with or without Additional Oxygenated Functional Groups by EFSA in 
FGE.08Rev5 (EFSA CEF Panel, 2012)11 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
For the candidate substance methyl methanethiosulphonate [FL-no: 12.159] (the only substance in 
subgroup X), there is an indication of a genotoxic potential in vitro. Furthermore, for three candidate 
substances (in subgroup III), 2-methylbutane-2-thiol [FL-no: 12.172], 2-methylpropane-2-thiol [FL-
no: 12.174] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and one candidate substance 
(in subgroup VII), 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], a concern for genotoxicity was also 
identified based on experimental evidence for [FL-no: 12.174] and the structural similarity among 
these four substances. Therefore, in the absence of further genotoxicity data, the Panel concluded that 
the Procedure could not be applied to these five substances.  
For four candidate substances, 3-mercaptooctanal [FL-no: 12.268] (subgroup III), 3-mercaptodecanal 
[FL-no: 12.269] (subgroup III), methanedithiol diacetate [FL-no: 12.271] (subgroup VIII) and 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] (subgroup V) no data on use as flavouring substances 
in Europe are available. Therefore, no intakes in Europe can be estimated and accordingly the Panel 
concluded that the Procedure could not be applied to these four substances.  
Thus, for in total nine candidate substances the Procedure could not be applied: [FL-no: 12.159, 
12.172, 12.174, 12.268, 12.269, 12.271, 12.295, 12.304 and 16.057]. 
For the safety evaluation of the remaining 71 candidate substances from chemical groups 20 and 30 
the Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise 
evaluations of the 71 substances evaluated through the Procedure are summarised in Table8. 
                                                     
11  The text is taken verbatim from the indicated reference source, but text related to subgroups not included in the present  
  FGE has been removed 
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Step 1 
The candidate substances were classified following the procedure established by Cramer et al. (Cramer 
et al., 1978). For the 71 candidate substances evaluated through the Procedure, 42 substances were 
classified into structural class I, 19 substances were classified into structural class II and 10 substances 
were classified into structural class III. 
Step 2 
Step 2 requires consideration of whether metabolic pathways exist to metabolise the candidate 
substances to innocuous products at the expected levels of intake. The candidate substances may be 
biotransformed to reactive metabolites, such as thiols, sulphoxides and sulphones and, in consequence, 
they are not predicted to be metabolised to innocuous products. Therefore, the evaluation of all 71 
candidate substances proceeds via the B-side of the Procedure scheme. 
Step B3 
The 42 substances in structural class I have estimated European daily per capita intakes ranging from 
0.0012 to 6.1 µgram, which is below the threshold of concern of 1800 µg/person/day. The 19 
substances evaluated through the Procedure in structural class II have estimated European daily per 
capita intakes ranging from 0.0024 to 2.4 µg, which is below the threshold of concern for class II of 
540 µg/person/day. The 10 substances in structural class III have estimated European daily per capita 
intakes ranging from 0.012 to 6.1 µg, which is below the threshold of concern for class III of 90 
µg/person/day. Accordingly, all 71 candidate substances proceed to step B4 of the Procedure. 
Step B4 
No adequate studies on candidate substances are available. Repeated-dose toxicity studies are 
available on some supporting substances, which, with very few exceptions, have been carried out 
testing only one dose, giving rise to no observed adverse effects. The results of adequate studies on 
supporting substances show a relatively high degree of variability in the reported No Observed 
Adverse Effect Levels (NOAELs), ranging from 0.06 to 250 mg/kg bw/day.  
The 20 candidate substances in subgroup I can be represented by the supporting substance dimethyl 
sulfide [FL-no:12.006], for which an adequate 90-day subchronic study is available, indicating that no 
adverse effects were produced by the highest oral dose tested (250 mg/kg body weight (bw)/day), 
which can be considered a NOAEL. The combined estimated daily per capita intake of 10 µg for the 
20 candidate substances in subgroup I corresponds to 0.17 µg/kg bw/day at a body weight of 60 kg. 
Thus, a margin of safety of 1.5 x 106 can be calculated. The 20 candidate substances in subgroup I are 
accordingly not expected to be of safety concern at the estimated levels of intake. 
Within subgroup III, adequate 90-day subchronic studies are available for four supporting secondary 
thiols, 2-mercapto-3-butanol [FL-no: 12.024], cyclopentanethiol [FL-no: 12.029], 2-, 3- and 10-
mercaptopinane [FL-no: 12.035] and 2,6-(dimethyl)thiophenol [FL-no: 12.082], which can be 
considered representative of the 11 candidate substances evaluated through the Procedure in this 
subgroup. In the four studies, no adverse effects were produced by the highest oral dose tested ranging 
from 0.06 up to 0.7 mg/kg bw/day. By adopting a conservative approach the lowest value (0.06 mg/kg 
bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 1.13 µg for 
the 11 candidate substances evaluated through the Procedure in subgroup III corresponds to 0.019 
µg/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3 x 103 can be calculated. The 11 
candidate substances in subgroup III, evaluated through the Procedure are accordingly not expected to 
be of safety concern at the estimated levels of intake. 
The two candidate substances in subgroup IV can be represented by two supporting substances, 
butane-2,3-dithiol [FL-no: 12.022] and octane-1,2-dithiol [FL-no: 12.034], for which adequate 90-day 
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subchronic studies are available. In the two studies, no adverse effects were produced by the almost 
identical highest oral doses tested, that is 0.7 mg/kg bw/day, which can be considered a NOAEL. The 
estimated daily per capita intake of 0.42 µg for the two candidate substances in subgroup IV 
corresponds to 0.005 µg/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 1.4 x 105 
can be calculated. The candidate substances in subgroup IV are accordingly not expected to be of 
safety concern at the estimated level of intake. 
Within subgroup V, adequate 90-day subchronic studies are available for two supporting substances 
dicyclohexyl disulfide [FL-no: 12.028] and benzyl methyl disulfide [FL-no: 12.068], which can be 
considered representative of the four candidate substances in this subgroup evaluated through the 
Procedure. In the two studies, no adverse effects were produced by the highest oral dose tested: 0.23 
and 1.15 mg/kg bw/day. By adopting a conservative approach, the lowest value (0.23 mg/kg bw/day) 
can be considered a NOAEL. The combined estimated daily per capita intake of 0.6 µg for the four 
candidate substances evaluated through the Procedure in subgroup V corresponds to 0.010 µg/kg 
bw/day at a body weight of 60 kg. Thus, a margin of safety of 2.3 x 105 can be calculated. The four 
candidate substances in subgroup V are accordingly not expected to be of safety concern at the 
estimated levels of intake. 
Within subgroup VII, adequate 90-day subchronic studies are available for five supporting substances, 
trithioacetone [FL-no: 15.009], 3,5-dimethyl-1,2,4-trithiolane [FL-no: 15.025], 2-methyl-4-propyl-1,3-
oxathiane [FL-no:16.030], 2-methyl-1,3-dithiolane [FL-no: 15.034] and 3-methyl-1,2,4-trithiane [FL-
no: 15.036], which can be considered representative for 12 of the candidate substances in this 
subgroup. In the 90-day studies, no adverse effects were produced by the only oral dose tested, 0.2, 
1.88, 0.44, 7 and 0.3 mg/kg bw/day, respectively. By adopting a conservative approach, the lowest 
value (0.2 mg/kg bw/day) can be considered a NOAEL. The combined estimated daily per capita 
intake of 3.9 µg for these 12 candidate substances in subgroup VII corresponds to 0.065 µg/kg bw/day 
at a body weight of 60 kg. Thus, a margin of safety of 3.1 x 103 can be calculated. These 12 substances 
are not expected to be of safety concern at the estimated levels of intake.  
For the remaining candidate substance in subgroup VII, 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134], a 
90-day study is available for the supporting substance 2,5-dihydroxy-2,5-dimethyl-1,4-dithiane [FL-
no: 15.006] that can be considered to be structurally related to this candidate substance. In the study no 
adverse effects were produced by the only oral dose tested, 3.14 mg/kg bw/day. Therefore the NOAEL 
is concluded to be 3.14 mg/kg bw/day for this supporting substance. The estimated daily per capita 
intake for the candidate substance 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] is 6.1 µg, which 
corresponds to 0.10 µg/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3.1 x 104 
may be calculated. The candidate substance is accordingly not expected to be of safety concern at the 
estimated level of intake. 
Within subgroup VIII, an adequate 90-day subchronic study is available for one supporting substance, 
ethyl thioacetate [FL-no: 12.018], which can be considered representative of the eight candidate 
substances evaluated through the Procedure in this subgroup. In the study, no adverse effects were 
produced by the highest oral dose tested: 6.63 mg/kg bw/day. Therefore, the NOAEL is concluded to 
be 6.63 mg/kg bw per day for ethyl thioacetate. The combined estimated daily per capita intake of 2.4 
µg for the eight candidate substances in subgroup VIII corresponds to 0.04 µg/kg bw/day at a body 
weight of 60 kg. Thus, a margin of safety of 1.7 x 105 can be calculated. The eight candidate 
substances in subgroup VIII are accordingly not expected to be of safety concern at the estimated 
levels of intake. 
The conclusion from step B4 is that for the 58 candidate substances belonging to subgroups I, III, IV, 
V, VII and VIII and evaluated through the Procedure, adequate NOAELs exist for the candidate 
substance or for structurally related substances providing adequate margins of safety at the estimated 
levels of intake. Therefore, these candidate substances are not expected to be of safety concern at the 
levels of exposure estimated by the MSDI approach.  
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The evaluations of the aliphatic and alicyclic thiols, mono-, di-, tri-, and polysulphides with or without 
additional oxygenated functional groups of FGE.08Rev5 are summarised in Table 8 
5.3. EFSA Considerations  
The 44 JECFA evaluated simple aliphatic and aromatic sulphides and thiols with and without an 
additional oxygenated functional group are distributed into six subgroups of structurally related 
substances. The subgrouping is the same as used in FGE.08Rev5. See Section 2.1.2 and Table 2.  
A new bacterial gene mutation  assay for 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] in 
FGE.74Rev3 has become available. This substance is considered to be supporting for the seven 
tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] in FGE.91. Based 
on these data the Panel considered that the seven tertiary thiols in FGE.91Rev2 can be evaluated 
through the Procedure. 
Table 2:  The Subgrouping of the 44 Simple Aliphatic and Aromatic Sulfides and Thiols in 
FGE.91Rev2.  
FL-no 
JECFA-
no 
EU Register name Structural formula Structural 
Class 
I Acyclic sulphides 
In FGE.08Rev5 this subgroup was represented by supporting substance [FL-no: 12.006], for which an adequate 
NOAEL is available (Butterworth et al., 1975). 
12.077 
460 
Benzyl methyl sulphide 
S
II 
12.146 
1691 
Methyl (methylthio)acetate 
S
O
O I 
12.162 
459 
Methyl phenyl sulphide 
S
II 
12.265 
1683 
2-Methyl-1-methylthio-2-butene 
S
I 
12.273 
1692 
3-(Methyl-thio)heptanal 
S
O
I 
12.285 
1688 
3-Methylthio-2-butanone 
S
O I 
12.286 
1689 
4-Methylthio-2-pentanone O
S
I 
12.287 
1690 
Methyl 3-(methylthio)butanoate S
O
O I 
17.036 
1710 
S-allyl-L-cysteine NH2
SHO
O
III 
III Monothiols (including tertiary monothiols) 
In FGE.08Rev5 the secondary monothiols were represented by supporting substances [FL-no: 12.024, 12.029, 
12.035, 12.082] for which adequate toxicological studies were available. The lowest value not giving rise to 
adverse effects was considered a NOAEL (Cox et al., 1974a; Morgareidge and Oser, 1970a; Oser, 1966; Peano 
et al., 1981). 
12.017 
1659 
Ethanethiol SH  I 
12.108 
1672 
Di-isopentyl thiomalate 
O
O
O
SH O III 
12.130 Heptane-1-thiol SH I 
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Table 2:  The Subgrouping of the 44 Simple Aliphatic and Aromatic Sulfides and Thiols in 
FGE.91Rev2.  
FL-no 
JECFA-
no 
EU Register name Structural formula Structural 
Class 
1663 
12.139 
1666 
2-Mercaptoanisole 
SH
O III 
12.242 
1675 
Methylthiomethylmercaptan SHS  I 
12.264 
1670 
4,2-Thiopentanone SH O I 
12.267 
1667 
Propyl-2-mercaptopropionate 
O
O
SH I 
12.276 
1671 
(S)-1-Methoxy-3-heptanethiol SH
O
I 
12.288 
1664 
Heptan-2-thiol SH I 
12.289 
1665 
1-Phenylethylmercaptan HS II 
12.290 
1674 
Methyl-3-mercaptobutanoate 
O
SH O I 
12.292 
1704 
Hexyl 3-mercaptobutanoate 
O
SH O
 
I 
12.297 
1708 
3-Mercaptoheptyl acetate 
O
O
SH
I 
Tertiary Monothiols 
Concern for genotoxic potential has been ruled out. 
No NOAEL could be identified for the tertiary monothiols or for sufficiently structurally related substances 
12.038 
561 
8-Mercapto-p-menthan-3-one O
SH
II 
12.085 
523 
p-Menth-1-ene-8-thiol 
SH
II 
12.137 
544 
3-Mercapto-3-methylbutan-1-ol 
HO
SH
I 
12.138 
549 
3-Mercapto-3-methylbutyl formate 
O O
SH
I 
12.145 
548 
4-Methoxy-2-methylbutane-2-thiol SH
O
I 
12.252 
1669 
4-Mercapto-4-methyl-2-pentanol OH
SH
I 
12.259 
1673 
1-Mercapto-p-menthan-3-one O
HS
II 
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Table 2:  The Subgrouping of the 44 Simple Aliphatic and Aromatic Sulfides and Thiols in 
FGE.91Rev2.  
FL-no 
JECFA-
no 
EU Register name Structural formula Structural 
Class 
IV Dithiols 
In FGE.08Rev5 this subgroup was represented by supporting substances [FL-no: 12.022, 12.034] for which 
adequate toxicolgical studies were available. The lowest value not giving rise to adverse effects was considered 
a NOAEL (Cox et al., 1974b; Cox et al., 1974c). 
12.243 
1661 
Dimercaptomethane HS SH  I 
12.284 
1709 
bis(1-Mercaptopropyl)sulfide 
S
SHSH I 
12.293 
1660 
Ethane-1,1-dithiol 
HS
SH I 
V Acyclic and cyclic disulphides 
In FGE.08Rev5 this subgroup was represented by supporting substances [FL-no: 12.028, 12.068] for which 
adequate toxicolgical studies were available. The lowest value not giving rise to adverse effects was considered 
a NOAEL (Cox et al., 1974b; Gallo et al., 1976). 
12.012 
1699 
Diethyl disulfide S
S
 I 
12.021 
1700 
Allyl propyl disulfide S
S
 II 
12.126 
1694 
Ethyl propyl disulfide 
S
S
 I 
12.153 
1693 
Methyl ethyl disulfide S S  I 
12.253 
1697 
Amyl methyl disulfide S
S
 I 
12.254 
1698 
Butyl ethyl disulfide S
S  I 
12.294 
1696 
Isopentyl methyl disulfide 
S
S
I 
VI Acyclic polysulphides 
The substances previously allocated to the group are no longer supported for use as flavouring substances in 
Europe by Industry.  
VII Mono-, di-, tri-, and poly-sulphides with thioacetal structure 
In FGE.08Rev5 this subgroup was represented by supporting substances [FL-no: 15.009; 15.025; 15.034; 
15.036; 16.030] for which adequate toxicolgical studies were available. The lowest value not giving rise to 
adverse effects was considered a NOAEL (BIBRA, 1976; Mondino, 1981; Griffiths et al., 1979; Cox et al., 
1973). 
12.240 
1684 
2,4,6-Trithiaheptane SSS  I 
12.274 
1687 
3,6-Diethyl-1,2,4,5-tetrathiane and 
3,5-diethyl-1,2,4-trithiolane mix in 
vegetable oil triglycerides 
S
S
S
SS
S S
II 
15.049 
1686 
3,5-Diethyl-1,2,4-trithiolane 
S
S
S
II 
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Table 2:  The Subgrouping of the 44 Simple Aliphatic and Aromatic Sulfides and Thiols in 
FGE.91Rev2.  
FL-no 
JECFA-
no 
EU Register name Structural formula Structural 
Class 
VIII Thioesters 
In FGE.08Rev5this subgroup was represented by supporting substances [FL-no: 12.018] for which an adequate 
NOAEL exists (Shellenberger, 1970).  
12.134 
1679 
S-Isopropyl 3-methylbut-2-
enethioate 
S
O I 
12.275 
1681 
Allylthio hexanoate 
S
O II 
X Sulphoxides/sulphones and sulphonates 
The substances previously allocated to the group are no longer supported for use as flavouring substances in 
Europe by Industry  
 
The Panel agrees with JECFA that all candidate substances in this FGE can be evaluated through the 
Procedure. 
For 10 of these substances the Panel did not agree with the way the JECFA carried out the evaluation. 
Three substances, di-isopentyl thiomalate [FL-no: 12.108], benzyl methyl sulphide [FL-no: 12.077] 
and methyl phenyl sulphide [FL-no: 12.162]), have been cleared by JECFA at step B5 (the MSDI < 
1.5 μg per person per day). This approach is not supported by the Panel (see section 2.1.2). 
However, for [FL no: 12.108] which belongs to subgroup III, NOAELs ranging from 0.06 to 0.7 
mg/kg bw/day are available based on adequate 90-day sub-chronic studies on the four supporting 
substances in subgroup III of FGE.08Rev5. These NOAELs have been reported for 3-mercapto-2-
butanol [FL-no: 12.024], cyclopentanethiol [FL-no: 12.029], 2-,3- and 10-mercaptopinane [FL-no: 
12.035] and 2,6-(dimethyl)-thiophenol [FL-no: 12.082] (Cox et al., 1974a; Morgareidge and Oser, 
1970a; Oser, 1966; Peano et al., 1981). Using the lowest NOAEL of 0.06 mg/kg bw and an EU MSDI 
of 0.012 µg/capita a margin of safety of 3 x 105 can be calculated. The Panel considered this margin of 
safety sufficiently large to conclude no safety concern at the estimated level of intake at step B4 of the 
Procedure. 
Because benzyl methyl sulphide and methyl phenyl sulphide [FL-no: 12.077 and 12.162] are sulphides 
the Panel has allocated them to subgroup I, despite the fact that there are no other sulphides with 
aromatic substituents in this subgroup. Thus, no structurally related substance occurs in this subgroup 
which can provide an adequate NOAEL to evaluate [FL-no: 12.077 and 12.162]. However, sulphides 
can be considered metabolites of thiols. For subgroup III (thiols), a common biotransformation 
pathway is methylation of the thiol to the corresponding sulphide followed by S-oxidation and 
elimination (FGE.08Rev5). Therefore, toxicity data of thiols can be used for the evaluation of 
sulphides assuming that the toxicity of thiols is higher than the toxicity of sulphides because of the 
greater reactivity of the thiol group as compared to the sulphide group. For the thiols in subgroup III, 
90 days studies are available for four substances, including one with an aromatic ring (2,6-
(dimethyl)thiophenol [FL-no: 12.082]). For this substance a NOAEL of 0.43 mg/kg bw/day was 
derived. Using this NOAEL of 0.43 mg/kg bw/day and the MSDIs of 0.09 µg/capita/day for benzyl 
methyl sulphide and of 0.012 µg/capita/day for methyl phenyl sulphide, respectively, margins of 
safety of 2.8 x 104 and 2.1 x 105, are derived. The Panel considered these margins of safety sufficiently 
large to conclude no safety concern at the estimated level of intake at step B4 of the Procedure. 
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For six of the seven tertiary thiols in the present FGE [FL-no: 12.038, 12.085, 12.137, 12.138, 
12.145, 12.252 and 12.259] the JECFA derived a NOAEL from a 90-day study on the secondary 
thiol, 2-mercapto-3-butanol [FL-no: 12.024] (Cox et al., 1974a). For [FL-no: 12.085] the JECFA has 
used a NOAEL derived from a 90-day study on the secondary thiol, cyclopentanethiol [FL-no: 12.029] 
(Morgareidge and Oser, 1970a).The Panel did not agree with the JECFA that the tertiary thiols are 
sufficiently structurally related to the secondary thiol substances used for deriving the NOAELs. Thus 
no NOAEL could be identified for the tertiary thiols or for sufficiently structurally related substances. 
Accordingly the Panel concluded at step B4 (contrary to the JECFA) that further data are required for 
the seven tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259]. 
For in total 37 substances [FL-no: 12.012, 12.017, 12.021, 12.077, 12.108, 12.126, 12.130, 12.134, 
12.139, 12.146, 12.153, 12.162, 12.240, 12.242, 12.243, 12.253, 12.254, , 12.264, 12.265, 12.267, 
12.273, 12.274, 12.275, 12.276, 12.284, 12.285, 12.286, 12.287, 12.288, 12.289, 12.290, 12.292, 
12.293, 12.294, 12.297, 15.049 and 17.036] the Panel concluded in line with the JECFA: “No safety 
concern at estimated levels of intake as flavouring substances” based on the MSDI approach at step B4 
of the Procedure. 
CONCLUSION  
This consideration deals with 44 simple aliphatic and aromatic sulphides and thiols with and without 
an additional oxygenated functional group which are in the Register and which were evaluated by the 
JECFA at its 53rd and 68th meetings.  
The Panel concluded that these 44 candidate substances are structurally related to the aliphatic and 
alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups 
evaluated by EFSA in the Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5). The 44 JECFA 
evaluated substances are distributed into six subgroups of structurally related substances. The 
subgrouping is the same as used in FGE.08Rev5. 
This revision is made because additional genotoxicity data have become available for 4-mercapto-4-
methyl-2-pentanone [FL-no: 12.169] from FGE.74Rev3, which is a representative for the group of 
tertiary monothiols and therefore covers the seven substances [FL-no: 12.038, 12.085, 12.137, 12.138, 
12.145, 12.252 and 12.259] in this FGE. In addition, data on production volume and specification 
were submitted.  
Although the available data are limited the Panel considered that for the 44 substances in FGE.91Rev2 
the genotoxicity data do not preclude evaluating these substances through the Procedure. 
However, the Panel noted that candidate substance 3-(methylthio)heptenal [FL-no: 12.273] contains 5 
to 7 % of an α,β -unsaturated aldehyde, (2-(E)-heptenal [FL-no: 05.150], for which a concern has been 
raised due to the presence of a structural alert for genotoxicity. This substance is a candidate 
flavouring substance which is under evaluation in FGE.200Rev1 (FGE.19 subgroup 1.1.1). 
The Panel agrees with the JECFA that all substances can be evaluated through the Procedure. For 34 
substances the conclusion was that they do not pose a safety concern when used as flavouring 
substance at their estimated intake based on the MSDI approach. 
For 10 substances [FL-no: 12.038, 12.077, 12.085, 12.108, 12.137, 12.138, 12.145, 12.162, 12.252 
and 12.259] the Panel did not agree with the application of the Procedure by the JECFA for the 
following reasons: 
For the substances [FL-no: 12.077, 12.108 and 12.162], the JECFA has cleared by the JECFA at step 
B5 (the MSDI < 1.5 μg person per day). However, the Panel considers that adequate NOAELs exist to 
evaluate these substances and concluded at step B4 “No safety concern at the estimated levels of 
intake based on the MSDI approach”. 
Flavouring Group Evaluation 91 Revision 2 
 
EFSA Journal 2014;12(6):3707 34
For the tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259], contrary 
to the JECFA, the Panel concluded that there are no adequate NOAELs for these candidate substances 
or from structurally related substances and that additional toxicity data are required to finalise the 
evaluation of these seven substances. 
For 34 substances, use levels have been provided by the Industry. The mTAMDI figures for five 
substances [FL-no: 12.264, 12.284, 12.274, 12.108 and 12.139] are above the threshold of concern for 
their structural classes. For these substances more reliable data are needed. On the basis of such data 
the flavouring substances should be reconsidered using the Procedure. For 10 substances [FL-no: 
12.038, 12.077, 12.085, 12.137, 12.138, 12.145, 12.162, 12.265, 12.267 and 17.036] for which use 
levels have not been provided, use levels are needed to calculate the mTAMDI values in order to 
identify those flavouring substances that need a more refined exposure assessment and to finalise the 
evaluation.  
In order to determine whether the conclusion for the 44 JECFA evaluated substances, for which the 
Panel concluded that they could be evaluated through the Procedure, can be applied to the materials of 
commerce, it is necessary to consider the available specifications. Specifications including complete 
purity criteria and identity are available for all 44 substances. 
Thus, for seven substances [FL-no: 12.038, 12.085, 12.137, 12.138, 12.145, 12.252 and 12.259] 
evaluated through the Procedure, the Panel concluded that additional toxicity data are required.  
For candidate substance 3-(methylthio)heptenal [FL-no: 12.273], which contains 5 to7 %  of an α,β-
unsaturated aldehyde, 2-(E)-heptenal, with a possible genotoxic potential, the Panel cannot conclude 
that the material of commerce for this candidate substance is not of safety concern, until either this 
component is cleared with respect to a concern for genotoxicity, or this component is removed from 
the commercial product. 
For 36 substances [FL-no: 12.012, 12.017, 12.021, 12.077, 12.108, 12.126, 12.130, 12.134, 12.139, 
12.146, 12.153, 12.162, 12.240, 12.242, 12.243, 12.253, 12.254, 12.264, 12.265, 12.26712.274, 
12.275, 12.276, 12.284, 12.285, 12.286, 12.287, 12.288, 12.289, 12.290, 12.292, 12.293, 12.294, 
12.297, 15.049  and 17.036] the Panel agrees with the JECFA conclusion “No safety concern at 
estimated levels of intake as flavouring substances based on the MSDI approach.”. 
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SUMMARY OF GENOTOXICITY DATA  
Table 3:  Genotoxicity Data (in vitro / in vivo) evaluated by JECFA (JECFA, 2008a) 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
In vitro 
12.275 
1681 
Allylthio hexanoate 
S
O Reverse Mutation S.typhimurium TA98, 
TA100, TA102, TA1535, 
TA1537 
5(a), 15(a), 50, 
150,500, 1500 or 
5000 µg/plate 
Negative(b) (King and 
Harnasch, 2002) 
12.274 
1687 
3,6-Diethyl-1,2,4,5-
tetrathiane and 3,5-
diethyl-1,2,4-trithiolane 
mix in vegetable oil 
triglycerides 
S
S
S
SS
S S
Reverse Mutation(c) S.typhimurium TA98, 
TA100, TA102, TA1535, 
TA1537 
0.1, 0.316, 1, 3, 
16 or10 µg/plate 
Negative(b) (Uhde, 2005) 
Reverse Mutation S.typhimurium TA98, 
TA100, TA102, TA1535, 
TA1537 
0.1, 0.316, 1, 3, 
16 or10 µg/plate 
Negative(b) (Uhde, 2005) 
12.021 
1700 
Allyl propyl disulfide 
S
S
 
Reverse Mutation(d) S.typhimurium TA97, 
TA98, TA100, TA102, 
TA1535, TA1537 
Up to 333 
µg/plate 
Negative(b) (Zeiger et al., 
1988) 
Allyl propyl disulfide (e) Reverse Mutation(f) S.typhimurium TA100 Not specified Negative(b) (Eder et al., 
1982b) 
Allyl propyl disulfide (g) Reverse Mutation(f) S.typhimurium TA100 0.0015 – 0.15 
µl/ml 
1.5 – 150 µg/ml 
Negative(b) (Eder et al., 
1980) 
(a):  Concentration tested in the absence of metabolic activation. 
(b):  With and without metabolic activation. 
(c):  Plate incorporation method. 
(d):  Preincubation method. 
(e):  Mixture of 32 % allyl propyl disulfide, 31 % propyl disulfide and 32 % allyl disulfide. 
(f):  Liquid suspension method. 
(g):  Mixture of 31 % allyl propyl disulfide, 37 % propyl disulfide and 32 % allyl disulfide. 
(h):  Calculated based on specific gravity of allyl propyl disulfide (0.999 - 1.005 g/ml). 
. 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012) 
Chemical Name  [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) Ames test  S. typhimurium TA100  0.004 – 0.44 µg/ml Negative  
(±S9) 
(Eder et al., 1982a) Review. No details on 
method and results 
reported. Only TA100 
used. 
Sister chromatid 
exchange  
Chinese hamster ovary cells  200 - 600 µg/ml Positive(a) (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Chromosomal 
aberrations  
Chinese hamster ovary cells  200 - 600 µg/ml Positive (a) (Musk et al., 1997) Limited quality of study. 
Insufficiently reported.
Di-(1-propenyl)-sulfid 
(mixture) [12.298] 
Ames test S. typhimurium TA98, TA100, 
TA102, TA1535, TA1537 
1 – 100 µg/plate Negative(a) (Stien, 2005) Un-published GLP study. 
Study considered valid. 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene 
[15.102] 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537  
50 – 5000 µg/plate  Negative
(±S9)  
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Cytogenetic assay  Human lymphocytes  12.5 – 125 µg/ml  Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
HPRT assay  Chinese hamster ovary cells  100 – 200 µg/ml Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  15.63 – 125 µg/ml  Negative
(±S9)  
(Pennwalt 
Corporation, 1987b) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Unscheduled DNA 
synthesis  
Human epithelial cells  2.5 – 5120 µg/ml  Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(1,4-Dithiane [15.066]) Ames test  S. typhimurium TA98, TA100  0.8 – 100 µ mol/plate (96.2 - 
12024 µg/plate)  
Positive   
(-S9) 
Negative  
(+S9)  
(Lee et al., 1994) Only two strains were 
tested, otherwise 
acceptable study. 
 Sister chromatid Chinese hamster ovary cells  2000 µM (240 µg/ml)  Negative (Lee et al., 1994) Insufficient quality. 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012) 
Chemical Name  [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
exchange  (±S9)   
Subgroup III – Monothiols 
2-Methylpropane-2-thiol 
[12.174] 
Ames test  
 
S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
10000 µg/plate  Negative 
(±S9)   
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Forward mutational 
MLTK assay  
L5178Y/tk+/- mouse lymphoma 
cells  
1000 µg/ml  Positive 
(-S9) 
Negative 
(+S9)  
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  1350 µg/ml  Negative 
(+S9) (b) 
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(Allyl mercaptan [12.004]) Modified Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
0.005 – 1.5 µl/ml (4.6 – 1400 
µg/ml)  
Negative  
(±S9)   
(Eder et al., 1980) Acceptable quality. 
(Benzyl mercaptan [12.005]) Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
3.6 mg/plate (3600 µg/plate) Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(2-Mercaptopropionic acid 
[12.039]) 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative 
(±S9)   
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzenethiol [12.080]) Ames test S. typhimurium TA98, TA100 25 – 500 µg/plate  Negative  
(±S9) 
(LaVoie et al., 
1979) 
Insufficient quality (only 
two strains were used, and 
all doses -except the 
lowest dose - were toxic). 
Subgroup IV – Dithiols 
(1,2-Ethanedithiol [12.066]) Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
5 doses up to 5000 µg/plate  Negative 
(±S9)   
(Phillips Petroleum 
Company, 1990b) 
Validity cannot be fully 
evaluated (only abstract 
provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  0.5 - 50 µg/ml  Positive
(±S9)   
(Pence et al., 1982) Acceptable quality. 
Forward mutational 
assay   
L5178Y/tk+/- mouse lymphoma 
cells  
150 µg/ml  Positive
 (-S9)   
(Pence et al., 1982) Positive only at cytotoxic  
concentrations. 
Forward mutational L5178Y/tk+/- mouse lymphoma 1 µg/ml  Negative (Pence et al., 1982) Insufficiently 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012) 
Chemical Name  [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
assay  cells  (+S9) documented. 
Subgroup V – Acyclic Di-, Tri-, and Poly-sulphides 
(Diallyl disulphide [12.008]) Modified Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
0.0015 – 0.15 µg/ml  Negative  
(±S9)   
(Eder et al., 1980) Acceptable quality. 
Sister chromatid 
exchange  
Chinese hamster ovary cells  2 - 25 µg/ml  Weakly 
positive 
(±S9) 
(Musk et al., 1997) Limited quality. 
Insufficiently reported. 
Chromosomal 
aberrations  
Chinese hamster ovary cells  2 - 25 µg/ml  Positive
(±S9) 
(Musk et al., 1997) Limited quality. 
Insufficiently reported. 
(Dimethyl disulphide 
[12.026]) 
Ames test  S. typhimurium TA98, TA100, 
TA102  
0.000011 – 1.1 mmol/plate  
(1.04 - 104000 µg/plate) 
Negative  
(±S9)   
(Aeschbacher et al., 
1989) 
Limited quality (only 3 
strains used). 
(Phenyl disulphide [12.043]) Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9)   
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzyl disulphide [12.081]) 
 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented.
Dibutyl disulphide [12.111] Forward mutational 
assay  
Mouse lymphoma cells  NR  Negative  
(-S9)   
(Dooley et al., 
1987) 
Validity cannot be fully 
evaluated (only abstract 
provided). 
Subgroup VIII – Thioesters 
(Methylthio 2-
(acetyloxy)propionate 
[12.203]) 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537,  
E. Coli WP2uvrA 
0.156-5.0 mg/plate (156-5000 
μg/plate 
Negative  
(±S9) 
(Watanabe and 
Morimoto, 1989a) 
Acceptable quality. 
(Methylthio 2-
(propionyloxy) propionate 
[12.227]) 
Ames test  
 
S. typhimurium TA98, TA100, 
TA1535, TA1537,  
E. Coli WP2uvrA 
0.156 – 5.0 mg/plate (156 - 
5000 µg/plate)  
Negative
(±S9)   
(Watanabe and 
Morimoto, 1989b) 
Acceptable quality. 
(Methylsulfinyl methane 
[12.175]) 
(synonym: dimethylsulfoxid, 
DMSO) 
Ames test  S. typhimurium TA97, TA98, 
TA100  
100000 – 300000 µg/plate  Negative
(±S9) 
(Brams et al., 1987) Insufficient method (3 
strains and 3 
concentrations only). 
Ames test  S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537  
100 – 10000 µg/plate  Negative
(±S9)   
(Zeiger et al., 1992) Acceptable quality. 
Ames test  S. typhimurium TA97, TA98, 0.1 – 0.4 ml/plate (100000 - Negative   (Hakura et al., Good quality study. 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012) 
Chemical Name  [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
TA100, TA102, TA104, 
TA1535, TA1538,  
E. Coli WP2  
400000 µg/plate)  (-S9) 1993) 
Ames test  S. typhimurium TA1537, 
TA2637,  
E. Coli WP2uvrA  
0.1 – 0.4 ml/plate (100000 - 
400000 µg/plate)  
Positive  
(-S9) (e)  
(Hakura et al., 
1993) 
Good quality study. 
Positive at high doses with 
reduced bacterial survival. 
Doses routinely used in 
Ames test were negative. 
NR: Not reported. 
(a): With and without metabolic activation at clearly cytotoxic concentrations. 
(b): A statistically significant increase in the number of SCEs per chromosome was seen at 1350 µg/ml and the 450 µg/ml dose level in the presence of metabolic activation; but no significant 
increase was seen in the remaining dose levels, and no dose level showed a two fold increase in SCEs; therefore, t-butyl mercaptan is not considered to be mutagenic. 
(c): With 100 µl/plate fecalase. 
(d): With 100 µl/plate S9 metabolic activation and 100 µl/plate fecalase. Negative results reported after 2 days of incubation. Results for TA98 test strain were positive after 5 days of 
incubation. 
(e): Positive results obtained at doses where lethal toxicity was observed. Negative results obtained at doses routinely used in Ames test. 
(f): Thiosulfonates in general and methyl methane thiosulfonate in particular, are non-specific antimicrobial agents that are active at low concentrations on prokaryotic bacteria, as well as on 
yeast and other eukaryotic fungi. This was even pointed out by Dorange et al. (1983). Therefore bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity of 
thiosulfonates. 
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Table 5:  Genotoxicity Data (in vivo) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012) 
Chemical Name [FL-no]  Test System Test Object Route Dose Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) In vivo mouse 
micronucleus test  
Mouse  Gavage 0.33 – 0.67 mM/kg 
(38 – 77 mg/kg)(a) 
Negative (Marks et al., 
1992) 
Insufficient quality. Mixture of three 
substances was tested. 
Subgroup III – Monothiols  
(2-Mercaptopropionic acid 
[12.039]) 
In vivo Basc test  Drosophila  Dietary 
route 
10 mM  
(1061 µg/ml) 
Negative (Wild et al., 1983) Limited quality (insufficiently 
documented). The article compiles 
results obtained with 76 substances in 3 
test systems. 
Subgroup V – Acyclic and cyclic Disulphides 
(Allyl disulphide [12.008])  In vivo mouse 
micronucleus test  
Mouse Gavage 0.33 – 0.67 mM/kg  
(48 – 98 mg/kg) (a)  
Negative  (Marks et al., 
1992) 
Insufficient quality. Mixture of three 
substances was tested. 
Subgroup VI – Acyclic Tri- and Polysulphides 
(Diallyl trisulphide [12.009]) In vivo mouse 
micronucleus test  
Mouse  Gavage 0.33 – 0.67 mM/kg 
(59 - 120 mg/kg) (a) 
Negative  (Marks et al., 
1992) 
Insufficient quality. Mixture of three 
substances was tested. 
Subgroup X – Sulphoxides/Sulphones and Sulphonates 
Methyl methane-
thiosulfonate [12.159] 
In vivo genetic mutation Nicotiana 
tabacum 
seeds  
- 2 - 4 mg/ml  
(2000 - 4000 
µg/ml)  
Negative  (Dorange et al., 
1983) 
Obscure test system(b). This assay 
cannot be regarded as standard test. 
In vivo genetic mutation Nicotiana 
tabacum 
seeds 
- 50 – 400 µg/ml  Negative  (Dorange et al., 
1983) 
Obscure test system(b). This assay 
cannot be regarded as standard test. 
(a):  Study used a mixture of allyl sulfide, allyl disulfide and ally trisulfide in the respective ratio, 68:20:12. 
(b):  Heterozygotic seeds were used. After exposure, the seeds were blotted on filter paper and planted in earthenware pots in medium normally used for planting tobacco. The leaves were 
analysed for alterations indicating genotoxicity. 
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Table 6:  Summary of Additional Genotoxicity Data on 2-methyl-4-oxopentane-2-thiol 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural 
formula 
End-point Test system Concentration Results Reference Comments 
12.169 2-Methyl-4-
oxopentane-2-thiol SH
O
 
Reverse 
mutation 
Salmonella 
typhimurium 
TA98, 
TA100, 
TA1535, 
TA1537 and 
TA102 
5, 15. 81, 50, 158.1, 
500, 
1581 and 5000 
μg/plate(a)
Negative (Mc Garry, 
2012) 
Valid GLP  study, in compliance with 
OECD 471 Guideline 
156.3, 312.5, 625.0, 
1250, 
2500 and 5000 μg 
/plate(a,b) 
Negative  
(a): In the absence and presence of S9-mix metabolic bioactivation. 
(b): Assay modified with pre-incubation in presence of S9-mix. 
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SUMMARY OF SAFETY EVALUATIONS 
Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.012 
1699 
Diethyl disulfide 
S
S
 0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.017 
1659 
Ethanethiol SH  0.49 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.114 
1701 
Diethyl trisulfide 
S
S
S  16 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. No longer 
supported by Industry 
(DG SANCO, 
2013b). 
 
12.126 
1694 
Ethyl propyl disulfide 
S
S
 0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.130 
1663 
Heptane-1-thiol SH  0.037 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.134 
1679 
S-Isopropyl 3-
methylbut-2-
enethioate S
O 0.012 
ND 
Class I 
B3: Intake below 
threshold 
d No safety concern at 
the estimated level of 
intake based on the 
No safety concern at 
the estimated level of 
intake based on the 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
B4: Adequate 
NOAEL exists 
MSDI approach. MSDI approach. 
12.137 
544 
3-Mercapto-3-
methylbutan-1-ol 
HO
SH  
8.6 
2 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.138 
549 
3-Mercapto-3-
methylbutyl formate 
O O
SH  
0.13 
0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.145 
548 
4-Methoxy-2-
methylbutane-2-thiol 
SH
O  
0.14 
0.8 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.146 
1691 
Methyl 
(methylthio)acetate S
O
O
 
0.24 
1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.153 
1693 
Methyl ethyl 
disulfide 
S
S  0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.240 
1684 
2,4,6-Trithiaheptane SSS  0.012 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.242 
1675 
Methylthiomethylmer
captan 
SHS
 0.012 
0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.243 
1661 
Dimercaptomethane HS SH  0.012 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.252 
1669 
4-Mercapto-4-
methyl-2-pentanol 
OH
SH  
0.012 
0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.253 
1697 
Amyl methyl 
disulfide 
S
S
 0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.254 
1698 
Butyl ethyl disulfide S
S  0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.256 
1695 
Ethyl propyl 
trisulfide 
S
S
S
 0.012 ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. No longer 
supported by Industry 
(DG SANCO, 
2013b). 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.264 
1670 
4,2-Thiopentanone SH O
 
0.12 
0.07 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.265 
1683 
2-Methyl-1-
methylthio-2-butene S
 
0.012 
0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.267 
1667 
Propyl-2-
mercaptopropionate 
O
O
SH
 
0.012 
0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.273 
1692 
3-(Methyl 
thio)heptanal S
O  
0.012 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Secondary 
component 2-(E)-
heptenal (5-7 %) 
correpond to [FL-no: 
05.150] which is 
under evaluation in 
FGE.200Rev1: 
additional 
genotoxicity data 
required. 
Register name to be 
changed to 3-(Methyl 
thio)heptanal. 
Secondary 
component 2-(E)-
heptenal (5-7 %) 
correpond to [FL-no: 
05.150] which is 
under evaluation in 
FGE.200Rev1: 
additional 
genotoxicity data 
required.
12.276 
1671 
(S)-1-Methoxy-3-
heptanethiol 
SH
O  
0.012 
2 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
NOAEL exists 
12.284 
1709 
bis(1-
Mercaptopropyl)sulp
hide S
SHSH
 
0.12 
0.6 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.285 
1688 
3-Methylthio-2-
butanone S
O
 
0.012 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.286 
1689 
4-Methylthio-2-
pentanone 
O
S  
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.287 
1690 
Methyl 3-
(methylthio)butanoat
e 
S
O
O
 
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.288 
1664 
Heptan-2-thiol SH
 
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.290 
1674 
Methyl-3-
mercaptobutanoate 
O
SH O
 
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.292 
1704 
Hexyl 3-
mercaptobutanoate 
O
SH O
 
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.293 
1660 
Ethane-1,1-dithiol 
HS
SH
 
0.012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.294 
1696 
Isopentyl methyl 
disulfide S
S  
0.012 
ND 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.297 
1708 
3-Mercaptoheptyl 
acetate 
O
O
SH  
0.0012 
0.01 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.021 
1700 
Allyl propyl disulfide 
S
S
 0.037 ND 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.038 
561 
8-Mercapto-p-
menthan-3-one 
O
SH
24 
2 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.077 
460 
Benzyl methyl sulfide 
S
 
0.09 
0.02 
Class II 
B3: Intake below 
threshold 
B4: No adequate 
NOAEL 
B5: Intake below 
1.5 µg/person/day 
f No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.085 
523 
p-Menth-1-ene-8-
thiol 
SH
 
23 
1 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.162 
459 
Methyl phenyl sulfide 
S  
0.012 
0.4 
Class II 
B3: Intake below 
threshold 
B4: No adequate 
NOAEL 
B5: Intake below 
1.5 µg/person/day 
f No safety concern at 
the estimated level of 
intake based on the 
MSDI. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI. 
12.259 
1673 
1-Mercapto-p-
menthan-3-one 
O
HS
 
0.24 
ND 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.274 
1687 
3,6-Diethyl-1,2,4,5-
tetrathiane and 3,5-
diethyl-1,2,4-
trithiolane mix in 
vegetable oil 
triglycerides 
S
S
S
SS
S S
0.61 
ND 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.275 
1681 
Allylthio hexanoate 
S
O
 
0.012 
ND 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.289 
1665 
1-
Phenylethylmercapta
n 
HS 0.012 
ND 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
15.049 
1686 
3,5-Diethyl-1,2,4-
trithiolane 
S
S
S  
0.61 
0.01 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.108 
1672 
Di-isopentyl 
thiomalate O
O
O
SH O
 
0.012 
ND 
Class III 
B3: Intake below 
threshold, 
B4: No adequate 
NOAEL 
B5: Intake below 
1.5 µg/person/day 
f No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
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Table 7:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2008a) 
FL-no 
JECFA
-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome 
on the 
named 
compound 
[(d) or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.139 
1666 
2-Mercaptoanisole 
SH
O
 
1.5 
ND 
Class III 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.272 
1702 
Propyl 
propanethiosulfonate S
S
O
O
 
0.012 
ND 
Class III 
B3: Intake below 
threshold 
B4: No adequate 
NOAEL 
Additional 
data 
required 
Genotoxicity data 
required. No longer 
supported by Industry 
(DG SANCO, 
2013b). 
 
17.036 
1710 
S-allyl-L-cysteine NH2
SHO
O  
30 
2 
Class III 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 109 / (0.1 x population in Europe (= 375 x 106) x 0.6 x 365)  =  µg/capita/day. 
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): Cleared by JECFA as intake below 1.5 µg/person/day. 
ND not determined 
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
0.3 
 
Class I 
B3: Intake below 
threshold, 
B4: Adequate 
NOAEL exists 
d f  
12.104 
 
Butane-2-thiol SH
 
0.18 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.106 
 
S-2-Butyl 3-
methylbutanethioate 
O
S
 
0.8 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.111 
 
Dibutyl disulfide 
S
S
 
0.37 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.112 
 
Dibutyl trisulfide 
S
S
S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.116 
 
Dimethyl tetrasulfide S
S
S
S
 
0.016 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.117 
 
Dipentyl sulfide S
 
0.0037 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.124 
 
Ethyl butyl sulfide S
 
0.037 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.125 
 
Ethyl propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.127 
 
Ethyl propyl sulfide S
 
0.085 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.129 
 
3-(Ethylthio)propan-1-
ol 
HO S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.135 
 
3-Mercapto-2-
methylpropionic acid 
HSHO
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.151 
 
Methyl butyl disulfide 
S
S
 
0.0061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.152 
 
Methyl butyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.158 
 
Methyl isoprenyl 
sulfide 
S
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.163 
 
Methyl prop-1-enyl 
sulfide 
S
 
0.0097 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.164 
 
Methyl prop-1-enyl 
trisulfide S
SS
 
0.0061 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.165 
 
S-Methyl 
propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.166 
 
Methyl propyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.167 
 
Methyl propyl 
tetrasulfide 
S
S
S
S
 
0.0037 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.178 
 
3-(Methylthio)butyric 
acid 
O
HO S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.180 
 
1-(Methylthio)ethane-
1-thiol 
SH
S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.181 
 
1-(Methylthio)pentan-
3-one 
S
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.182 
 
2-
(Methylthio)propionic 
acid 
S
HO
O
 
0.011 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.183 
 
3-
(Methylthio)propionic 
acid SHO
O
 
0.21 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.189 
 
S-(Methylthiomethyl) 
2-methylpropanethioate 
S S
O
 
0.061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.191 
 
Pentane-1-thiol SH
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.196 
 
S-Prenyl 
thioisobutyrate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.199 
 
Ethanethioic acid 
HS
O
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.200 
 
1,1-bis(Ethylthio)-
ethane 
S S
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.205 
 
Mercaptoacetaldehyde 
SH
O
 
0.011 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.214 
 
Isobutyl-3-
(methylthio)butyrate 
S
O
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.221 
 
S-Prenyl 
thioisopentanoate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.250 
 
3-Mercaptohexanal O SH
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.266 
 
Methyl-2-
mercaptopropionate SH
O
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d h  
12.277 
 
3-(Methylthio)propyl 
butyrate 
O S
O
 
6.1 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.278 
 
3-Acetyl-
mercaptohexyl acetate 
O
O
S
O 1.2 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.282 
 
(S)-Methyl 
octanethioate 
O
S
 
0.24 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d g  
12.298 
 
Di-(1-propenyl)-sulfid 
(mixture) 
S
S
S
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.299 
 
3-(Methylthio)propyl 
hexanoate 
SO
O
 
0.061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.303 
 
3-Pentanethiol SH
 
0.03 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.306 
 
3-(Methylthio)-decanal 
S
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.304 
 
Ethyl-2-mercapto-2-
methyl propanoate 
O
O
SH
0.012 
 
Class I 
No evaluation 
  Pending update, as new 
genotoxicity data have 
become available. 
12.172 
 
2-Methylbutane-2-thiol 
HS
 
0.15 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.174 
 
2-Methylpropane-2-
thiol 
SH
 
0.0012 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.268 
 
3-Mercaptooctanal SHO
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.269 
 
3-Mercaptodecanal SHO
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.271 
 
Methanedithiol 
diacetate 
S S
O O
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
NOAEL 
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.096 
 
Allyl methyl sulfide S
 
0.99 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.097 
 
Allyl methyl 
tetrasulfide S
S
S
S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.098 
 
Allyl prop-1-enyl 
disulfide S
S
 
0.17 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.099 
 
Allyl propyl sulfide S
 
1.6 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.100 
 
Allyl propyl trisulfide S
S
S
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
Flavouring Group Evaluation 91 Revision 2 
 
EFSA Journal 2014;12(6):3707 59
Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.177 
 
8-(Methylthio)-p-
menthan-3-one 
O
S
 
0.37 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.302 
 
2-Butanol, 4-mercapto-
3-methyl SH
OH
 
0.061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.305 
 
2-Mercapto-4-heptanol SHOH
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.047 
 
3,5-Di-isobutyl-1,2,4-
trithiolane 
SS
S
 
0.024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.048 
 
3,5-Di-isopropyl-1,2,4-
trithiolane 
SS
S
 
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.056 
 
3,6-Dimethyl-1,2,4,5-
tetrathiane 
SS
S S
 
0.0024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f   
15.083 
 
3-Methyl-1,2,4-
trithiolane 
SS
S
 
0.0024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
15.102 
 
Tetrahydrothiophene S
 
0.024 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
  
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S
 
0.073 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.110 
 
2,4,6-Trimethyl-1,3,5-
trithiane 
S
S S
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.111 
 
1,2,4-Trithiolane 
S
S S
 
2.4 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.125 
 
4-Tetrahydrothio-
pyranone 
S
O
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.295 
 
3,5-Dimethyl-1,2-
dithiolane-4-one 
S S
O
 
 
Class II 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
16.057 
 
2,4,4-Trimethyl-1,3-
oxathiane 
O
S
0.0012 
 
Class II 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.120 
 
2,8-Epithio-p-menthane 
S
 
3.7 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 No longer supported by 
Industry (DG SANCO, 
2013b). 
12.136 
 
3-Mercapto-2-
oxopropionic acid 
HSHO
O
O
 
0.24 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.300 
 
1,1-Propanedithiol SH
SH
 
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.301 
 
Methyl-2-oxo-propyl 
disulfide S
S
O
 
0.061 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.007 
 
Spiro(2,4-dithia-1-
methyl-8-
oxabicyclo[3.3.0]octane
-3,3'-(1'-oxa-2'-methyl)-
cyclopentane) and 
Spiro(2,4-dithia-6-
methyl-7-
oxabicyclo[3.3.0]octane
-3,3'-(1'-oxa-2'-methyl)-
cyclopentane) 
O
S
S
O
O
S
S
O
I
II
6.1 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 8:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
15.081 
 
Lenthionine S S
S S
S
 
0.012 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.134 
 
2,5-Dihydroxy-1,4-
dithiane 
S
S
HO
OH
 
6.1 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.062 
 
trans-2-Methyl-4-
propyl-1,3-oxathiane 
S
O
 
1.0 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.114 
 
2-Pentyl-4-propyl-1,3-
oxathiane 
S
O
 
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.122 
 
4-Methyl, 2-propyl, 1-
3-oxathiane 
S
O
 
0.24 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.159 
 
Methyl 
methanethiosulfonate S
O
O
S
 
0.061 
 
Class III 
No evaluation 
  No longer supported by 
Industry (DG SANCO, 
2013b). 
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 109 / (0.1 x population in Europe (= 375 x 106) x 0.6 x 365)  = µg/capita/day. 
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): No safety concern at the estimated level of intake of the material of commerce meeting the specification requirement (based on intake calculated by the MSDI approach). 
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(g): Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or 
information on stereoisomerism. 
(h): No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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APPENDIX A: USE LEVELS AND mTAMDI 
Normal and maximum use levels provided by the Flavour Industry (EFFA, 2004; EFFA, 2006; Flavour Industry, 2004; Flavour Industry, 2005; Flavour 
Industry, 2006; Flavour Industry, 2007a) in accordance with the Commission Regulation (EC) No 1565/2000 (EC, 2000). 
The normal and maximum use levels are shown in Table A.1. Based on these normal use levels mTAMDI figures can be calculated (see Table A.2). 
Table A.1: Normal and Maximum use levels (mg/kg) available for JECFA evaluated Substances in FGE.91Rev2 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.012 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.017 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
-
0.2 
1
0.1 
0.5
0.2 
1
0.1 
0.2
0.1 
0.2
- 
- 
- 
-
0.1 
0.5
0.2 
1
0.1 
0.5
0.2 
1
0.4 
2
0.1 
0.5
12.021 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.108 0.4 
2 
0.2 
1 
0.4 
2 
0.3 
1.5 
- 
- 
0.4 
2 
0.2 
1 
0.4 
2 
0.1 
0.4 
0.1 
0.4 
- 
- 
- 
- 
0.2 
1 
0.4 
2 
0.2 
1 
0.4 
2 
1 
5 
0.2 
1 
12.114 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.3 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.126 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.3 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.130 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.134 0.4 
2 
0.2 
1 
0.4 
2 
0.3 
1.5 
- 
- 
0.4 
2 
0.2 
1 
0.4 
2 
0.1 
0.4 
0.1 
0.4 
- 
- 
- 
- 
0.2 
1 
0.4 
2 
0.2 
1 
0.4 
2 
1 
5 
2 
1 
12.139 0.4 
2 
0.2 
1 
0.4 
2 
0.3 
1.5 
- 
- 
0.4 
2 
0.2 
1 
0.4 
2 
0.1 
0.4 
0.1 
0.4 
- 
- 
- 
- 
0.2 
1 
0.4 
2 
0.2 
1 
0.4 
2 
1 
5 
0.2 
1 
12.146 0.4 
2 
0.2 
1 
0.4 
2 
0.3 
1.5 
- 
- 
0.4 
2 
0.2 
1 
0.4 
2 
0.1 
0.4 
0.1 
0.4 
- 
- 
- 
- 
0.2 
1 
0.4 
2 
0.2 
1 
0.4 
2 
1 
5 
0.2 
1 
12.153 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.3 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.240 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.242 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.243 0.2 0.1 0.2 0.2 - 0.2 0.1 0.2 0.1 0.1 - - 0.1 0.2 0.1 0.2 0.4 0.1 
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Table A.1: Normal and Maximum use levels (mg/kg) available for JECFA evaluated Substances in FGE.91Rev2 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
1 0.5 1 1 - 1 0.5 1 0.2 0.2 - - 0.5 1 0.5 1 2 0.5 
12.252 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.253 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.254 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.256 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.259 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.4 
2 
0.1 
0.5 
12.264 5 
10 
5 
20 
- 
- 
2 
10 
2 
10 
- 
- 
- 
- 
10 
30 
3 
20 
- 
- 
- 
- 
- 
- 
5 
30 
- 
- 
1 
5 
5 
10 
5 
30 
- 
- 
12.273 1 
10 
0.1 
1 
- 
- 
2 
10 
2 
10 
- 
- 
- 
- 
10 
50 
3 
20 
- 
- 
- 
- 
- 
- 
2 
10 
- 
- 
1 
10 
1 
10 
5 
30 
- 
- 
12.274 10 
30 
5 
20 
- 
- 
5 
20 
5 
20
- 
-
- 
-
10 
30
10 
20
- 
-
- 
- 
- 
-
10 
30
- 
-
1 
5
5 
10
10 
20
- 
-
12.275 0.4 
2 
0.4 
2 
- 
- 
0.2 
10 
0.2 
10 
2 
10 
- 
- 
2.5 
12.5 
0.3 
1.5 
0.3 
1.5 
- 
- 
- 
- 
0.5 
5 
- 
- 
0.05 
0.5 
0.25 
1.3 
0.5 
2.5 
- 
- 
12.276 0.001 
0.01 
0.01 
0.1 
0.001 
0.01 
0.001 
0.01 
- 
- 
0.001 
0.01 
0.002 
0.02 
0.002 
0.02 
0.002 
0.02 
0.002 
0.02 
- 
- 
- 
- 
0.003 
0.03 
0.003 
0.03 
0.001 
0.005 
0.005 
0.05 
0.001 
0.01 
0.001 
0.01 
12.284 0.05 
1.25 
0.05 
1.25 
0.5 
12.5 
0.05 
1.25 
0.05 
1.25 
5 
125 
1 
25 
0.5 
12.5 
0.05 
1.25 
0.05 
1.25 
- 
- 
- 
- 
0.05 
1.25 
- 
- 
5 
125 
5 
125 
0.05 
1.25 
0.05 
1.25 
12.285 1 
5 
- 
- 
0.5 
0.7 
- 
- 
- 
- 
- 
- 
- 
- 
0.8 
1 
0.2 
0.5 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
0.5 
6 
- 
- 
- 
- 
- 
- 
12.286 0.5 
0.7 
- 
- 
0.5 
0.7 
- 
- 
- 
-
- 
-
- 
-
0.8 
1
2 
0.5
- 
-
- 
- 
- 
-
- 
-
- 
-
0.5 
0.6
- 
-
- 
-
0.5 
1
12.287 0.01 
10 
0.001 
10 
0.01 
10 
0.05 
10 
- 
- 
- 
- 
- 
- 
- 
- 
0.05 
10 
- 
- 
0.001 
10 
- 
- 
0.05 
10 
- 
- 
0.001 
5 
- 
- 
0.05 
10 
0.05 
10 
12.288 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
4 
10 
- 
- 
- 
- 
- 
- 
12.289 0.001 
0.008 
- 
- 
- 
- 
0.001 
0.008 
- 
- 
0.002 
0.025 
- 
- 
0.002 
0.04 
0.002 
0.025 
- 
- 
- 
- 
- 
- 
0.005 
1 
- 
- 
0.001 
0.02 
0.002 
0.025 
- 
- 
0.1 
0.5 
12.290 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
0.5 
5 
- 
- 
- 
- 
- 
- 
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Table A.1: Normal and Maximum use levels (mg/kg) available for JECFA evaluated Substances in FGE.91Rev2 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.292 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
0.5 
5 
- 
- 
- 
- 
- 
- 
12.293 - 
- 
0.2 
2 
- 
- 
0.2 
2 
- 
- 
- 
- 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
0.6 
5 
- 
- 
0.2 
2 
- 
- 
1 
5 
- 
- 
12.294 - 
- 
- 
- 
0.25 
0.5 
- 
- 
- 
- 
- 
- 
- 
- 
0.25 
0.5 
1 
1.5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.5 
1 
- 
- 
- 
- 
0.25 
0.5 
12.297 0.01 
0.1 
0.1 
1 
0.01 
0.1 
0.01 
0.1 
- 
- 
0.01 
0.1 
0.02 
0.2 
0.02 
0.2 
0.02 
0.2 
0.02 
0.2 
- 
- 
- 
- 
0.03 
0.3 
0.03 
0.3 
0.01 
0.05 
0.05 
0.5 
0.01 
0.1 
0.01 
0.1 
15.049 0.2 
1 
0.1 
0.5 
0.2 
1 
0.2 
1 
- 
- 
0.2 
1 
0.1 
0.5 
0.2 
1 
0.1 
0.2 
0.1 
0.2 
- 
- 
- 
- 
0.1 
0.5 
0.2 
1 
0.1 
0.3 
0.2 
1 
0.4 
2 
0.1 
0.5 
 
 
Table A.2: Estimated intakes based on the MSDI- and the mTAMDI approach – FGE.91Rev2 
FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of 
concern 
(µg/person/day) 
12.012 Diethyl disulfide 0.012 ND 78 Class I 1800
12.017 Ethanethiol 0.49 ND 78 Class I 1800 
12.114 Diethyl trisulfide 16 ND 78 Class I 1800 
12.126 Ethyl propyl disulfide 0.012 ND 78 Class I 1800 
12.130 Heptane-1-thiol 0.037 ND 78 Class I 1800 
12.134 S-Isopropyl 3-methylbut-2-enethioate 0.012 ND 370 Class I 1800
12.137 3-Mercapto-3-methylbutan-1-ol 8.6 2 ND Class I 1800 
12.138 3-Mercapto-3-methylbutyl formate 0.13 0.1 ND Class I 1800 
12.145 4-Methoxy-2-methylbutane-2-thiol 0.14 0.8 ND Class I 1800 
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Table A.2: Estimated intakes based on the MSDI- and the mTAMDI approach – FGE.91Rev2 
FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of 
concern 
(µg/person/day) 
12.146 Methyl (methylthio)acetate 0.24 1 160 Class I 1800 
12.153 Methyl ethyl disulfide 0.012 ND 78 Class I 1800 
12.240 2,4,6-Trithiaheptane 0.012 ND 78 Class I 1800 
12.242 Methylthiomethylmercaptan 0.012 0.1 78 Class I 1800 
12.243 Dimercaptomethane 0.012 ND 78 Class I 1800 
12.252 4-Mercapto-4-methyl-2-pentanol 0.012 0.1 78 Class I 1800 
12.253 Amyl methyl disulfide 0.012 ND 78 Class I 1800 
12.254 Butyl ethyl disulfide 0.012 ND 78 Class I 1800 
12.256 Ethyl propyl trisulfide 0.012 ND 78 Class I 1800
12.264 4,2-Thiopentanone 0.12 0.07 2000 Class I 1800 
12.265 2-Methyl-1-methylthio-2-butene 0.012 0.1 ND Class I 1800 
12.267 Propyl-2-mercaptopropionate 0.012 0.1 ND Class I 1800 
12.273 3-(Methyl thio)heptanal 0.012 ND 1800 Class I 1800 
12.276 (S)-1-Methoxy-3-heptanethiol 0.012 2 1.9 Class I 1800 
12.284 bis(1-Mercaptopropyl)sulphide 0.12 0.6 2000 Class I 1800 
12.285 3-Methylthio-2-butanone 0.012 ND 320 Class I 1800 
12.286 4-Methylthio-2-pentanone 0.012 0.01 430 Class I 1800 
12.287 Methyl 3-(methylthio)butanoate 0.012 0.01 9 Class I 1800 
12.288 Heptan-2-thiol 0.012 0.01 1400 Class I 1800 
12.290 Methyl-3-mercaptobutanoate 0.012 0.01 320 Class I 1800 
12.292 Hexyl 3-mercaptobutanoate 0.012 0.01 320 Class I 1800 
12.293 Ethane-1,1-dithiol 0.012 0.01 230 Class I 1800 
12.294 Isopentyl methyl disulfide 0.012 ND 300 Class I 1800 
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Table A.2: Estimated intakes based on the MSDI- and the mTAMDI approach – FGE.91Rev2 
FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of 
concern 
(µg/person/day) 
12.297 3-Mercaptoheptyl acetate 0.0012 0.01 19 Class I 1800 
12.021 Allyl propyl disulfide 0.037 ND 78 Class II 540 
12.038 8-Mercapto-p-menthan-3-one 24 2 ND Class II 540 
12.077 Benzyl methyl sulfide 0.09 0.02 ND Class II 540 
12.085 p-Menth-1-ene-8-thiol 23 1 ND Class II 540 
12.162 Methyl phenyl sulfide 0.012 0.4 ND Class II 540 
12.259 1-Mercapto-p-menthan-3-one 0.24 ND 78 Class II 540 
12.274 3,6-Diethyl-1,2,4,5-tetrathiane and 3,5-diethyl-1,2,4-trithiolane mix in 
vegetable oil triglycerides 
0.61 ND 2200 Class II 540 
12.275 Allylthio hexanoate 0.012 ND 430 Class II 540 
12.289 1-Phenylethylmercaptan 0.012 ND 14 Class II 540 
15.049 3,5-Diethyl-1,2,4-trithiolane 0.61 0.01 78 Class II 540 
12.108 Di-isopentyl thiomalate 0.012 ND 160 Class III 90 
12.139 2-Mercaptoanisole 1.5 ND 160 Class III 90 
12.272 Propyl propanethiosulfonate 0.012 ND ND Class III 90 
17.036 S-allyl-L-cysteine 30 2 ND Class III 90
ND: No intake data available 
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ABBREVIATIONS 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
HPRT  Hypoxanthine Phosphoribosyl transferase 
ID  Identity 
IP  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  Micronucleated Binucleate cells 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
No  Number 
NOAEL No Observed Adverse Effect Level 
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NMR  Nuclear Magnetic Resonance 
NTP  National Toxicology Program 
PCE  Polychromatic erythrocyte 
RI  Replication Index 
SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
UDS  Unscheduled DNA Synthesis 
WHO  World Health Organisation 
